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ABSTRACT
Trypanosoma brucei is the causative agent of human African trypanosomiasis, a
disease affecting over 15,000 people annually. During its life cycle, T. brucei encounters
a number of changes in environmental conditions as it is passed between the mammalian
host and tsetse fly vector. These parasites are unique in that they compartmentalize
glycolysis in highly specialized, essential organelles called glycosomes. While it has
been demonstrated that glycosomal composition changes in response to life cycle
differentiation, environmentally dependent changes in glycosome composition had not
previously been demonstrated. Here I present data demonstrating that glycosome
composition changes in response to glucose, a nutrient whose availability fluctuates
throughout T. brucei’s life cycle. We used a fluorescent organelle reporter system to
demonstrate that glycosomes are remodeled in response to changes in environmental
conditions in the insect stage, procyclic form (PF) parasite. We also provide evidence
that a membrane protein in the peroxin family is involved in glycosome matrix protein
import, TbPEX13.1, localizes to the ER in PF T. brucei cultured in low glucose
conditions. Furthermore, we describe the glucose dependent heterogeneity of
glycosomes within parasite populations and show preliminary investigations focused on
determining the mechanisms that regulate glycosome protein expression. Such dynamic
nature and heterogeneity has not previously been demonstrated in trypanosome
glycosomes. Together the studies presented in this dissertation, in particular the duallocalization of TbPEX13.1 to glycosomes and the ER, provide support for the existences
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of an ER-derived de novo mechanism of glycosome biogenesis. Such a pathway has
been proposed to occur but has never been demonstrated experimentally.

iii

DEDICATION
For Marty and Norah.

iv

ACKNOWLEDGMENTS
The work presented in this dissertation would not have been possible without the
guidance and support of my advisor, Dr. Meredith Morris. Having the opportunity to be
her first graduate student is an honor and privilege that I will always be grateful for. She
has truly shaped me into the confident scientist that I am today. I would also like to
thank my committee, Dr. Kim Paul, Dr. Julia Frugoli and Dr. Terri Bruce. The wisdom
and support they have shared over the course of my work at Clemson University has been
invaluable. In addition, I would like to thank Dr. James Morris, who has served as a
mentor and challenged me every day. I am forever grateful to have had the privilege of
working with an all-star crew in the Morris lab. In particular, Terral Patel without whom
much of this work would not have been possible. Elizabeth Kahney, Michael Harris,
Yijian Qiu, Logan Crowe, Walker Blanding, Stephen Patrick, Alex Beaver, Jillian
Milanes and an army of amazing undergraduate students have provided friendship and
support throughout all of the ups and downs of graduate school. I would also like to
acknowledge the faculty, staff and students of the Eukaryotic Pathogens Innovation
Center as well as the Department of Genetics and Biochemistry. I have learned and
grown so much over the past few years and it has been an honor to do so with all of you.

Last, I would like to thank my family and friends for their love and support. I would not
be who or where I am today without them.

v

TABLE OF CONTENTS
Page
TITLE PAGE .................................................................................................................... i
ABSTRACT..................................................................................................................... ii
DEDICATION ................................................................................................................ iv
ACKNOWLEDGMENTS ............................................................................................... v
LIST OF TABLES .......................................................................................................... ix
LIST OF FIGURES ......................................................................................................... x
CHAPTER
I.

GLYCOSOME BIOGENESIS IN TRYPANOSOMES AND THE DE NOVO
DILEMMA .............................................................................................. 1
Abstract .................................................................................................... 2
Glycosomes enable parasite survival in multiple environments .............. 4
Glycosomes are related to peroxisomes, which proliferate by both
growth and division of existing organelles and de novo
biogenesis from the ER ................................................................ 6
Recent studies suggest glycosomes can proliferate de novo in
trypanosomes ............................................................................. 10
Glycosomes biogenesis is likely influenced by extracellular glucose
levels .......................................................................................... 14
References .............................................................................................. 19

II.

ENVIRONMENTALLY-REGULATED GLYCOSOME PROTEIN
COMPOSITION IN THE AFRICAN TRYPANOSOME..................... 26
Abstract .................................................................................................. 27
Introduction ............................................................................................ 28
Materials and Methods ........................................................................... 32
Results .................................................................................................... 36
Discussion .............................................................................................. 46
Acknowledgments.................................................................................. 51
References .............................................................................................. 51

vi

Table of Contents (Continued)
Page
III.

USING FLUORESCENT PROTEINS TO MONITOR GLYCOSOME
DYNAMICS IN THE AFRICAN TRYPANOSOME........................... 55
Short Abstract ........................................................................................ 56
Long Abstract......................................................................................... 56
Introduction ............................................................................................ 58
Protocol .................................................................................................. 62
Representative Results ........................................................................... 72
Discussion .............................................................................................. 75
Acknowledgments.................................................................................. 77
References .............................................................................................. 77

IV.

LOCALIZATION OF A TRYPANOSOME PEROXIN TO THE
ENDOPLASMIC RETICULUM ........................................................... 81
Abstract .................................................................................................. 82
Introduction ............................................................................................ 83
Materials and Methods........................................................................... 86
Results .................................................................................................... 88
Discussion .............................................................................................. 99
Acknowledgments................................................................................ 104
References ............................................................................................ 105

V.

UNDERSTANDING THE GLUCOSE DEPENDENT REGULATION
OF GLYCOSOMAL PROTEIN EXPRESSION ................................ 110
Abstract ................................................................................................ 111
Introduction .......................................................................................... 112
Materials and Methods......................................................................... 115
Results .................................................................................................. 119
Discussion ............................................................................................ 125
Acknowledgments................................................................................ 131
References ............................................................................................ 131

VI.

SUMMARY AND FUTURE DIRECTIONS ............................................ 136
References ............................................................................................ 142

vii

Table of Contents (Continued)
Page
APPENDICES ............................................................................................................. 145
A:
B:

HATbPEX13.1 Expression ........................................................................ 146
Preliminary Mass Spectrometry Analysis.................................................. 147

viii

LIST OF TABLES
Table

Page

3.1

SDM79 solid components ............................................................................ 62

3.2

SDM79 liquid components .......................................................................... 63

3.3

Cytomix recipe ............................................................................................. 65

ix

LIST OF FIGURES
Figure

Page

1.1

De novo biogenesis may facilitate production of new glycosomes after
autophagy of old organelles ................................................................... 13

1.2

Proposed model for influence of extracellular glucose levels on
glycosome biogenesis ............................................................................ 16

1.3

Glycosomal matrix protein import is more tightly regulated when
cultured in glucose rich media ............................................................... 17

2.1

Heterogeneous distribution of PF-PTS2-FP ................................................ 37

2.2

Western blot analysis of dim and bright cells .............................................. 39

2.3

Transmission electron microscopy .............................................................. 41

2.4

Glycosome composition is regulated by extracellular glucose levels ......... 42

2.5

Kinetics of medium-dependent glycosome remodeling .............................. 44

2.6

Passage into fresh medium triggers changes in glycosome composition .... 45

2.7

Proposed model for glycosome dynamics in T. brucei ................................ 46

3.1

Fluorescent glycosome reporter system ....................................................... 61

3.2

Glucose-dependent glycosome composition................................................ 74

3.3

Glycosome remodeling ................................................................................ 75

4.1

TbPex13.1 localizes with ER marker proteins in density gradient and
has multiple domains ............................................................................. 89

4.2

Glycosome and ER morphology is maintained in low glucose
conditions ............................................................................................... 92

4.3

HATbPex13.1 localizes to glycosomes in SDM79 glucose rich media ...... 93

4.4

HATbPex13.1 cells have altered glycosome and ER morphology when
grown in SDM80 low glucose media..................................................... 95

x

List of Figures (Continued)
Figure

Page

4.5

Deletion of the SH3 domain does not alter the glucose dependent
localization of HAPex13.1 ..................................................................... 97

4.6

HATbPEX13.1DPTS localizes to glycosome in high and low glucose
conditions ............................................................................................... 98

5.1

Glycosome composition changes in response to glucose availability ....... 120

5.2

Glycosome protein expression is down regulated and mRNA abundance
is altered in low glucose....................................................................... 123

5.3

Aldolase stability is not altered in low glucose ......................................... 124

5.4

Polysomes decrease in low glucose conditions ......................................... 125

6.1

Hypothesized model of environmentally regulated glycosome
heterogeneity and dynamic biogenesis ................................................ 139

xi

CHAPTER ONE
GLYCOSOME BIOGENESIS IN TRYPANOSOMES AND THE DE NOVO
DILEMMA
Sarah T. Bauer, Meredith T. Morris

Eukaryotic Pathogens Innovation Center
Department of Genetics and Biochemistry
Clemson University
Clemson, SC 29634

Submitted for publication – PLOS Neglected Tropical Diseases
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Abstract
Trypanosomatid parasites, including Trypanosoma and Leishmania, are the causative
agents of lethal diseases threatening millions of people around the world. These
organisms compartmentalize glycolysis in essential, specialized peroxisomes called
glycosomes. Peroxisome proliferation can occur through growth and division of existing
organelles and de novo biogenesis from the endoplasmic reticulum. The level that each
pathway contributes is debated. Current evidence supports the concerted contribution of
both mechanisms in an equilibrium that can vary depending on environmental conditions
and metabolic requirements of the cell. Homologs of a number of peroxins, the proteins
involved in peroxisome biogenesis and matrix protein import, have been identified in
Trypanosoma brucei. Based on these findings, it is widely accepted that glycosomes
proliferate through growth and division of existing organelles; however, to our
knowledge a de novo mechanism of biogenesis has not been directly demonstrated. Here
we review recent findings that provide support for the existence of an ER derived de novo
pathway of glycosome biogenesis in T. brucei. Two studies recently identified PEX13.1,
a peroxin involved in matrix protein import, in the ER of T. brucei. In other eukaryotes,
peroxins including PEX13 have been found in the ER in cells undergoing de novo
biogenesis of peroxisomes. In addition, PEX16 and PEX19 have been characterized in T.
brucei, both of which are important for de novo biogenesis in other eukaryotes. Because
glycosomes are rapidly remodeled via autophagy during life cycle differentiation, de
novo biogenesis could provide a rapid method of restoring glycosome populations
following turnover. Together, the findings we summarize provide support for the
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hypothesis that glycosome proliferation occurs through growth and division of preexisting organelles and de novo biogenesis from the ER and that the level each
mechanism contributes is influenced by glucose availability.
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Glycosomes enable parasite survival in multiple environments
Trypanosoma brucei is the protozoan parasite responsible for human African
trypanosomiasis (HAT), a lethal disease affecting over 15,000 people living in subSaharan Africa (1), and nagana, a wasting disease in cattle (2). T. brucei belongs to
Kinetoplastida, a class of protozoan parasites named for a mass of mitochondrial DNA,
called the kinetoplast, situated at the base of the flagellum in a single, intricate
mitochondrion (2, 3). This class also includes a number of other disease causing
parasites including Trypanosoma cruzi, the parasite responsible for American
trypanosomiasis, and the genus Leishmania, encompassing a number of species
responsible for leishmaniasis (2–5). Combined, these diseases threaten millions of
people around the world and have serious social and economic impact (1). Due to the
cost burden, harsh side effects, and rise in resistance to currently available drugs,
identifying new drug targets is crucial (1, 3).
T. brucei parasites are transmitted by tsetse flies. Bloodstream form (BSF) T.
brucei dwell in the bloodstream and lymphatic system of their mammalian hosts. When a
tsetse fly takes in a blood meal, ingested parasites differentiate into procyclic forms (PF)
in the midgut of the fly. PFs can then migrate to the salivary glands of the fly and
differentiate into metacyclic forms and be transmitted to the next mammalian host (2, 6,
7). Throughout the lifecycle, T. brucei encounters a number of environments with
different available nutrients. In the mammalian bloodstream, glucose is abundant, being
maintained at 5 mM and BSF parasites rely solely on glycolysis for the generation of
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ATP. In the tsetse fly midgut glucose levels fall after the bloodmeal to undetectable
levels within 15 minutes (7).
Unlike other eukaryotes in which glycolysis is a cytosolic process, T. brucei
compartmentalizes enzymes involved in glycolysis in single-membrane bounded
organelles called glycosomes (5, 8, 9). These organelles are evolutionarily related to
peroxisomes and harbor a number of proteins involved in import and biogenesis that are
homologous to peroxisome proteins in higher eukaryotes. These proteins are called
peroxins (discussed in further detail in section II) (3, 5).
Glycosomes are essential to parasite survival, likely due to compartmentalization
of key metabolic enzymes. For example, the glycolytic enzymes hexokinase and
phosphofructokinase are not inhibited by their products and compartmentalization of
glycolysis likely prevents these enzymes from depleting ATP within the cell (9, 10).
Disruption of glycosome biogenesis or glycosome protein import results in
mislocalization of these enzymes to the cytoplasm and cell death (11, 12).
Compartmentalization of glycolysis enables parasite survival in the various
environments encountered during its lifecycle. In BSF parasites, ATP is generated
exclusively through glycolysis, with up to 90% of glycosomal protein content involved in
glycolysis (5, 13). PF parasites generate ATP via glycolysis when glucose is present but
switch to amino acid metabolism when it is absent (8, 14). In this stage, less than 50%
of the total glycosome protein repertoire is involved in glycolysis (14). PFs have a fully
functional mitochondrion and protein components of the TCA cycle, electron transport
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chain, and proline and threonine metabolism located in the mitochondrion are
upregulated (16).
The essential nature of glycosomes in the pathogenic BSF lifecycle stage and the
uniqueness of the organelles make them ideal targets for drug development (17). While
much about glycosomal matrix protein import and organelle function in T. brucei has
been resolved, understanding about glycosome biogenesis is lacking. Specifically, it is
unclear the extent to which proliferation by multiplication of existing organelles or de
novo processes involving the ER contribute to glycosome replication. Here, we discuss
our current understanding of glycosome biogenesis and summarize data supporting the
existence of a de novo mechanism of glycosome biogenesis, heretofore unappreciated in
T. brucei.

Glycosomes are related to peroxisomes, which proliferate by both growth and
division of existing organelles and de novo biogenesis from the ER
Glycosomes are considered specialized peroxisomes because they share similar
structure, function, and homologous peroxins (PEX) involved in protein import and
biogenesis. Both organelles are membrane bounded microbodies with electron dense
matrices. They lack DNA and import fully folded proteins post-translationally (9, 18,
19). Peroxisomes are diverse organelles and activities vary with organism, cell type, and
environment (20). While glycosomes share a number of pathways with peroxisomes,
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such as beta-oxidation of fatty acids and reduction of reactive oxygen species, they are
unique in that they harbor enzymes involved in glycolysis (3, 9, 19, 21).
Glycosomes harbor homologs to yeast, mammal, and plant peroxin proteins that
participate in matrix protein import, membrane protein insertion, and organelle fission (3,
5). At least 13 peroxin homologs have been identified in kinetoplastids and although the
overall sequence identity of these peroxins ranges between 15-35% when compared to
homologs in other organisms, their activities are well conserved (5). Like peroxisomes,
glycosomal matrix proteins are targeted for import by the peroxisomal targeting signals,
PTS1 or PTS2. PTS1s are motifs consisting of three amino acid residues ((S/A/C)(K/R/H)-L) that are located on the C-terminus of glycosomal proteins. PTS2s consist of
a nine amino acid sequence ((R/K)(L/V/I)X5-(Q/H)(L/A)) located on the N-terminus of
glycosomal matrix proteins. These PTS1 and PTS2 signals are recognized by cytosolic
receptor peroxins, PEX5 and PEX7, for PTS1 and PTS2 respectively. PEX5 and PEX7
associate with a docking complex in the glycosomal membrane that contains PEX13 and
PEX14, where the cytosolic receptor and cargo are translocated into the glycosomal
matrix (3, 5). While recycling of PEX7 after cargo delivery is not well understood, PEX5
is mono-ubiquitinated by the ubiquitin conjugating enzyme, PEX4, and recycled back
into the cytoplasm (5, 20).
Peroxins also regulate the abundance and size of peroxisomes and glycosomes.
Growth and division of peroxisomes is regulated by the integral membrane peroxin,
PEX11, which directs elongation of peroxisomes that then undergo constriction by
dynamin-GTPase (20, 22). Silencing of PEX11 in Saccharomyces cerevisiae blocks
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fission resulting in fewer, larger peroxisomes (22, 23). Similarly silencing of TbPEX11
in T. brucei results in fewer, larger glycosomes (24).
Mechanisms of de novo biogenesis have been characterized in yeasts and
mammalian cells. PEX3, PEX16, and PEX19 are hallmark peroxins for this pathway.
PEX19 is a cytosolic receptor that recognizes membrane peroxisomal targeting signals
(mPTS) on newly synthesized peroxisomal membrane proteins (PMP). Like matrix
proteins, most PMPs are synthesized on free ribosomes in the cytosol. The PEX19-PMP
docks with PEX3, an integral peroxisomal membrane peroxin involved in the insertion of
PMPs (3, 20, 22, 25). Although the function of PEX16 differs slightly among different
species, in mammalian cells it has been demonstrated to recruit PEX3 and other PMPs to
the ER (25, 26). Mutation of PEX3 or PEX19 in yeast and PEX3, PEX16, or PEX19 in
mammalian cells results in cells devoid of peroxisomes, which are restored upon
complementation with functional gene copies, demonstrating the importance of these
peroxins in de novo peroxisome biogenesis (27–39).
Several mechanisms of ER-dependent peroxisome proliferation have been
proposed (reviewed in 20,23). In the heterotypic fusion model, yeast PEX3 forms preperoxisomal domains within the ER. Other PMPs, including docking complex peroxins
(PEX13 and PEX14), and the RING (really interesting novel gene) finger peroxins
involved in PEX5 receptor recycling (PEX2, PEX10, and PEX12), are trafficked to the
ER. Pre-peroxisomal vesicles (ppV) containing either docking complex PMPs or RING
finger peroxins bud from the ER independently. These individual, import-incompetent
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ppVs each containing a portion of the import machinery can then fuse and form importcompetent peroxisomes (40).
In the vesicle maturation model, PEX3 localizes to the ER in a PEX16-dependent
process. These ppVs, containing PEX3 and PEX16, bud from the ER and then are
capable of importing PMPs. The ppVs consecutively mature into organelles that support
peroxisome protein import. These ppVs can fuse with currently existing peroxisomes,
contributing new lipids and PMPs to the growth and division mechanism of biogenesis
(41).
While we have gained significant understanding of how proteins are targeted to
and imported into glycosomes, our understanding of how these organelles are formed and
multiply (ie. glycosome biogenesis) is lacking. Although PEX16 and PEX19 have both
been characterized (42, 43), the key peroxin in de novo biogenesis of peroxisomes in
other eukaryotes, PEX3, has yet to be identified in any kinetoplastid genome database.
With the low sequence identity maintained between homologous peroxins in different
species, this is not unexpected (5). However, without knowing the identity of PEX3,
characterizing a de novo process of glycosomes biogenesis in T. brucei remains a
challenge. In addition, many studies of de novo biogenesis rely on silencing genes
yielding cells devoid of peroxisomes and successive complementation to restore
peroxisomes (44). Such studies are challenging in T. brucei because glycosomes are
essential (17). Nevertheless, a number of recent findings provide support for the
existence of a de novo process of glycosome biogenesis in T. brucei.
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Recent studies suggest glycosomes can proliferate de novo in trypanosomes
In yeast and mammals, several peroxins localize to the ER during de novo
biogenesis of peroxisomes (20, 22, 25, 44). In pulse-chase experiments PEX3 fused to
yellow fluorescent protein localized to ER foci before being trafficked to peroxisomes
(45). Other PEXs including PEX2, PEX3, PEX8, PEX10, PEX11, PEX13, PEX14,
PEX15, PEX16, PEX17, PEX30, and PEX31 have been localized to ER concentrated in
areas where ppVs are generated (25, 40, 45–51). Furthermore, in mouse dendritic cells
PEX13 localized to lamellar structures that bud from the ER, giving rise to mature
peroxisomes (52).
In a recent proteomic study, Güther et al used affinity purification to isolate
glycosomes from cells expressing GFP-tagged TbPEX13.1, and characterized the
glycosomes of PF T. brucei by SILAC quantitative proteomics. Notably the
GFP.TbPEX13.1 fusion was detected in vesicles containing ER proteins (53). We have
also noted association of TbPEX13.1 with the ER. We found that TbPEX13.1 localized
to foci within the ER in PF T. brucei when the parasites were grown under low glucose
conditions (54). Much like ER localized peroxins in other organisms, it is possible that
localization of TbPEX13.1 to foci in the ER may be occurring at sites where new
glycosomes or pre-glycosomal vesicles bud.
PEX16 plays a pivotal role in the de novo biogenesis of peroxisomes in some
yeast and mammalian cells (20, 22, 25, 26, 44). In Yarrowia lipolytica, PEX16
negatively regulates peroxisome fission (55). Y. lipolytica PEX16s are N-glycosylated in
the ER, and mutation to ER exit machinery negatively impacts ER exit of PEX16 (26,
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46). In mammalian cells, PEX16 ER exit depends on Sec16B in ER exit sites (43, 56,
57). TbPEX16 was recently characterized in T. brucei. Silencing of TbPEX16 resulted
in a decrease in glycosome number. Remaining glycosomes were no longer
symmetrically distributed throughout the cell but instead sequestered to the posterior half
of the parasite (43). T. brucei expresses a single Sec16 homolog of human Sec16B (43,
58). The TbSec16 ER exit site is located between the kinetoplast and nucleus (58) in the
anterior end of the trypanosome opposite of where glycosomes are sequestered in cells
lacking TbPEX16 (43). Kalel et al. propose and we agree that TbPEX16 may be targeted
to the ER in T. brucei and that TbPEX16 silencing may interfere with the budding of
glycosomes through the TbSec16ER exit site. This would limit the contribution of de
novo biogenesis, yielding a decreased number of organelles in this area of the cell (43).
PEX19 also plays an important role in the de novo biogenesis of peroxisomes.
Silencing of PEX19 in S. cerevisiae and Hansenula polymorpha results in cells devoid of
peroxisomes while complementation with functional variants of PEX19 restores
peroxisome populations (30, 38, 39). Analogous results have been observed in
mammalian cells (33). In a similar manner, TbPEX19 silencing in T. brucei slowed
parasite growth in media containing glucose and resulted in a decrease in the total
number of glycosomes per cell. When cultured in the absence of glucose, TbPEX19
silencing was less detrimental to cell growth rate likely because mislocalization of
glycosomal matrix proteins is not lethal (42). Because complete disruption of glycosome
biogenesis is toxic to T. brucei when cells are cultured in the presence of glucose (11,
12), it is possible that a more complete knock down of TbPEX19 could be generated in
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the absence of glucose (42). Such complementation experiments in T. brucei could
demonstrate the existence of an ER-dependent mechanism of glycosome biogenesis.
Peroxisomes are degraded through an autophagic process called pexophagy,
which is often triggered by environmental factors (59). In S. cerevisiae, fatty acids
trigger the proliferation of peroxisomes that are degraded when cells are moved to
glucose media (60). Environmentally-induced changes in peroxisome composition also
occur in the methylotrophic yeast, H. polymorpha. In these cells peroxisomes that are
induced in methanol are then degraded when the cells are transferred to glucose (61).
T. brucei parasites encounter a number of environmental changes in which
nutrient availability varies. Extracellular glucose levels fluctuate between ~5 mM in the
mammalian bloodstream to undetectable levels in the tsetse fly vector (7). Concomitant
with these changes, glycosome composition is altered (21, 62–64). Like peroxisomes,
glycosomes associate with lysosomes and get degraded through autophagy during BSFPF differentiation (62). Glucose dependent changes in glycosome composition that occur
in PF parasites occur within three hours, a time frame consistent with that of autophagy
(63, 64). Generation of new glycosomes could provide a way to restore the glycosome
populations after autophagy with organelles containing a protein repertoire best suited for
the cell’s new environment (Fig 1.1).
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Figure 1.1. De novo biogenesis may facilitate production of new glycosomes after
autophagy of old organelles.
(A) Autophagy enables turnover of existing glycosomes. Glucose availability changes
through the life cycle of T. brucei, ranging from undetectable levels to ~5 mM. In
response to an increase or decrease in glucose availability, “old” glycosomes with
compositions best suited for prior environmental conditions can be degraded via
autophagy. (B) “New” organelles with protein repertoires better suited to the new levels
of glucose in the environment can be generated from the ER. (C) Once these new
glycosomes are generated, they can be maintained through growth and division. This
process enables cells to remodel glycosome composition and adapt to changing glucose
levels.
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Glycosomes biogenesis is likely influenced by extracellular glucose levels
Mechanisms of de novo peroxisome biogenesis are well established in yeast and
mammals, however, a similar mechanism of biogenesis in kinetoplastids has not been
directly demonstrated. Because of the similarities in glycosome and peroxisome
mechanisms of matrix protein import, PMP insertion, and organelle remodeling, it seems
logical that glycosome proliferation could also occur through an ER dependent
mechanism. Localization of peroxins to the ER, analogous phenotypes obtained from
silencing key de novo biogenesis peroxins, and similarities in organelle maintenance and
turnover provide support that like peroxisomes, de novo biogenesis of glycosomes likely
occurs in T. brucei.
There is contradicting evidence providing support for the primary mechanism of
peroxisome biogenesis. The current consensus is that growth and division of existing
organelles and ER derived de novo mechanisms occur synergistically and that the level
that each mechanism contributes varies depending on the organism, cell type, and
environmental condition. For example, yeast peroxisomes are produced primarily
through growth and division of existing organelles when cells are grown on oleic acid,
but there is a switch to de novo biogenesis when the organism is transferred to media
containing glucose (25, 65).
We hypothesize that de novo glycosome biogenesis and growth and division of
existing organelles both occur in PF T. brucei and that environmental triggers,
particularly glucose availability, influences the level at which each contributes. We
propose that in high glucose, glycosomes proliferate primarily through the growth and
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division of existing organelles while in low glucose conditions glycosomes multiply
through an ER derived de novo mechanism (Fig 1.2).
Generation of peroxisomes through growth and division is kinetically faster than
generation from the ER (20). We hypothesize that in glucose rich media glycosomes
proliferate rapidly through growth and division, allowing maintenance of metabolic flux,
while preventing glucose toxicity (Fig 1.3). Although de novo mechanisms of biogenesis
are kinetically less favorable, peroxisome composition can be altered through autophagy
(20). Degrading “old” glycosomes via autophagy could yield a temporary source of
substrates to satisfy metabolic needs (in the form of glycosome resident proteins) while
clearing the way for the generation of “new” glycosomes from the ER, which are better
suited for growth under glucose poor conditions.
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Figure 1.2. Proposed model for influence of extracellular glucose levels on
glycosome biogenesis
(A) When cultured in media containing glucose, glycosomes proliferate rapidly through
TbPEX11 dependent growth and division of pre-existing organelles to facilitate rapid
import of glycosome proteins that are toxic if mislocalized. Under low glucose
conditions, the slower de novo biogenesis mechanism plays a larger role in glycosome
proliferation. Under glucose poor conditions, the need for rapid import is not essential.
In this pathway, TbPEX13.1 and TbPEX16 are first inserted into the ER membrane via
TbPEX19 and get incorporated into budding pre-glycosomal vesicles. (B) Growth and
division and de novo mechanisms of glycosome biogenesis occur synergistically and the
level at which each mechanism contributes is glucose dependent. –Glc (glucose poor, <
0.05 mM), +Glu (glucose rich ~5 mM)
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Figure 1.3. Glycosomal matrix protein import is more tightly regulated when
cultured in glucose rich media.
(A) Digitonin fractionations of cells grown in high glucose (+Glc) and low glucose (-Glc)
reveal glycosomal proteins are detected outside of glycosomes under low glucose
conditions. Digitonin is a detergent that permeabilizes cell membranes. Increasing
digitonin concentration (mg dig/mg PF) added to cells consecutively permeabilizes
membrane bound compartments within the cell. Samples are analyzed by western blot,
probing with antibodies raised against an ER marker (BiP), a glycosomal matrix protein
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involved in glycolysis (aldolase), and a glycosomal fluorescent reporter system consisting
of a peroxisomal targeting signal (PTS2) fused to an eYFP (PTSeYFP). While BiP is
released at the same concentration of digitonin under both conditions, both aldolase and
PTSeYFP are released at lower concentrations of digitonin under low glucose conditions
when compared to high glucose conditions. These experiments suggest that mislocalized
glycosomal proteins can be detected extraglycosomally under low glucose conditions.
(B) In high glucose, glycosomal proteins localize exclusively to glycosomes and any
misloclaization is lethal to cells. Under low glucose conditions, mislocalization of
glycosomal matrix proteins is more tolerated and matrix proteins can be detected in the
cytoplasm prior to import. Glycosomal proteins depicted in green.

In our current model under conditions where glycosomes are generated through
de novo biogenesis, PEX13, PEX16, and potentially other membrane peroxins localize to
the ER and aggregate in foci where new glycosomes bud. This would explain the
localization of TbPEX13.1 to the ER in the absence of glucose, conditions under which
de novo biogenesis may be the primary mechanism of organelle formation. If TbPEX16
does play a role in de novo biogenesis, silencing in glucose rich media would disrupt the
contribution of de novo biogenesis, resulting in the absence of glycosomes in the ER exit
area of the cell observed by Kalel et al (43) but not from other regions of the cell where
glycosomes are primarily proliferating through growth and division. In glucose poor
conditions, TbPEX16 silencing may result in a more dramatic decrease in the number of
glycosomes if the parasites are relying on a de novo mechanisms of biogenesis in the
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absence of glucose. Similarly, silencing TbPEX19 in low glucose conditions may result
in glycosome deficient parasites as mislocalization of glycolytic enzymes is anticipated to
be more tolerated in T. brucei under these conditions (12).
In the future, characterization of peroxin localization and silencing peroxins in
low glucose conditions may provide insight into the existence of a de novo mechanism of
biogenesis and whether mechanisms of glycosome biogenesis differ with changes in
extracellular conditions. Complementing silenced peroxins and restoring glycosome
populations would also provide evidence of de novo glycosome formation. Better
understanding of the mechanism of de novo biogenesis in glycosomes would allow us to
gain knowledge of how glycosome populations are maintained and remodeled through a
balance of growth and division, de novo biogenesis, and autophagy.
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Abstract
Trypanosomes compartmentalize many metabolic enzymes in glycosomes, peroxisomerelated microbodies that are essential to parasite survival. While it is understood that
these dynamic organelles undergo profound changes in protein composition throughout
life cycle differentiation, the adaptations that occur in response to changes in
environmental conditions are less appreciated. We have adopted a fluorescent-organelle
reporter system in procyclic T. brucei by expressing a fluorescent protein (FP) fused to a
glycosomal targeting sequence (PTS2). In these cell lines, PTS2-FP is localized within
import competent glycosomes and organelle composition can be analyzed by microscopy
and flow cytometry.

Using this reporter system, we have characterized parasite

populations that differ in their glycosome composition. In glucose-rich media two
parasite populations are observed; one population harbors glycosomes bearing the full
repertoire of glycosome proteins while the other parasite population contains glycosomes
that lack the usual glycosome resident proteins but do contain the glycosome membrane
protein TbPEX11. Interestingly, these cells lack TbPEX13, a protein essential for the
import of proteins into the glycosome. This bimodal distribution is lost in low-glucose
media.

Furthermore, we have demonstrated that changes in environmental conditions

trigger changes in glycosome protein composition. These findings demonstrate a level of
procyclic glycosome diversity heretofore unappreciated and offers a system by which
glycosome dynamics can be studied in live cells. This work adds to our growing
understanding of how the regulation of glycosome composition relates to environmental
sensing.
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Introduction
Trypanosoma brucei, the causative agent of human African trypanosomiasis, has
a complex life cycle, with developmental stages in the bloodstream of the mammalian
host and the tsetse fly vector. Each host provides a distinct environment in which the
parasites must survive. Bloodstream form (BSF) parasites are bathed in glucose and
generate ATP exclusively by glycolysis. While in the tsetse fly, the procyclic form (PF)
parasites experience a drop in glucose levels with a concomitant increase in the
availability of amino acids (namely proline). Under these conditions, the parasite adapts
its metabolism, generating ATP from both glycolysis and amino acid metabolism (1).
In trypanosomes, many of the enzymes involved in glycolysis are contained
within membrane-bounded organelles called glycosomes (reviewed in (2-4)). Similarities
between the metabolic activity and the matrix protein import machinery of glycosomes
and peroxisomes indicate an evolutionary relationship between the two organelles. In
contrast to peroxisomes, however, glycosomes are essential, making mechanisms of
glycosome biogenesis and maintenance attractive drug targets.
Glycosome dynamics are governed by a number of processes including organelle
biogenesis, protein import, and changes in protein composition. In trypanosomes, a
number of proteins involved in import have been characterized and recent studies have
begun to identify processes involved in glycosome turnover and remodeling (5-7).
However, very little is known about organelle biogenesis.
Proper regulation of glycosome number and composition is essential to T. brucei.
Silencing of trypanosome PEX proteins involved in glycosome matrix protein import
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(TbPEX5, 7, 10, 6, 12, 14) causes the mislocalization of glycosome proteins to the
cytosol and compromised growth (8-12). Reduction in the expression of PEX genes
involved in glycosome biogenesis (TbPEX11and TbPEX19) through RNA interference
(13, 14), results in parasites harboring fewer, larger glycosomes, while overexpression of
TbPEX11 results in cells with many smaller glycosomes (14). As observed after
silencing of other PEX genes, reduction in levels of TbPEX11 and TbPEX19 also
resulted in growth arrest.
T. brucei glycosomes are extensively remodeled during differentiation between
BSF and PF parasites. In a recent study, 159 proteins from the glycosomes of BSF and
PF were identified by proteomics (15). Of these proteins, approximately 35% were found
in both stages of the life cycle. These constitutively expressed proteins included enzymes
involved in glycolysis, purine salvage, pyrimidine biosynthesis, phospholipid degradation
and glycerol-ether lipid biosynthesis. Forty-two percent of the proteins were PF-specific
and included proteins involved in the pentose phosphate pathway, the Calvin-Benson
cycle and oxygen radical and peroxide detoxifying enzymes.
While it is understood that the metabolic repertoire of the glycosome is variable,
the details of glycosome biogenesis and changes in protein composition are unknown.
Recent work suggests that glycosomal proteins can be turned over during the
differentiation process in a pathway that is mechanistically analogous to autophagy (16).
Glycosomes colocalize with lysosomes during differentiation when there is a change in
glycosome protein expression. Autophagy of glycosomes may also play a role in the
parasites’ response to the environment, as this pathway appears to be induced under
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starvation conditions when parasites are moved from nutrient-rich culture to PBS (16,
17). PBS-induced autophagy is not restricted to T. brucei, but has also been reported in
the related kinetoplastid, Leishmania major (18). In contrast to our knowledge of the
changes that occur during the differentiation process, less is known about how the protein
composition of PF glycosomes changes in response to different environmental
conditions.
In yeast and mammalian cells, peroxisomes can proliferate through the growth
and division of existing organelles as well as through de novo synthesis from the
endoplasmic reticulum. Aside from the observations that the silencing and
overexpression of TbPEX11 leads to defects in glycosome number and morphology,
nothing is known about how glycosomes proliferate through the growth and division of
existing organelles and, to our knowledge, a de novo pathway of glycosome biogenesis in
T. brucei has not been examined. Searches of the trypanosome genome have failed to
identify any homologs of genes involved in de novo biogenesis, however, this is not
surprising as these proteins are not well conserved and trypanosome sequences are highly
divergent from higher eukaryotes.
To study glycosome dynamics, we have adopted a fluorescent-organelle reporter
system used to study peroxisome biogenesis in yeasts and mammals for use in procyclic
form T. brucei. In this system, mature glycosomes import glycosomally-targeted
fluorescent protein while immature organelles do not. Using flow cytometry and electron
microscopy, we have identified and characterized two parasite populations that differ in
their glycosome composition. One population contains “mature” glycosomes harboring
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the expected repertoire of glycosomal proteins including TbPEX13, a protein essential for
import of proteins into glycosomes, while the other population contains glycosomes, as
demonstrated by EM, but expressed little or no glycosome proteins including TbPEX13.
The relative proportions of each parasite population varied in different media conditions.
In the presence of glucose, two distinct populations were present; one “dim” population
harboring immature glycosomes and one “bright” population harboring mature
glycosomes, with very few cells of intermediate fluorescence observed. Interestingly, in
low-glucose media this bimodal population structure was lost and a range of cells with
different fluorescence intensity was observed. When parasites were moved from lowglucose media into media containing 5 mM glucose, cells of intermediate fluorescence
were lost within 24 h. In addition to changes in steady state glycosome composition
under different media conditions, changes in glycosome expression as monitored by
PTS2-FP expression was observed in live cells during changes in environmental
conditions. This change was initiated within 3 h of cell passage from log-phase culture to
fresh media and was complete within 24 h.
The results presented here demonstrate a level of glycosome diversity previously
unrecognized. Furthermore, this is the first demonstration that PF parasites harbor
immature glycosomes and provides the first suggestion that T. brucei glycosomes may
proliferate via a de novo pathway. The glycosome reporter system utilized in these
studies provides a rapid, high-throughput, real-time protocol to monitor processes such as
autophagy, which likely regulate glycosome remodeling, in live cells.
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Materials and Methods
Reagents
All reagents were purchased from Fisher Scientific unless specified.

Growth and transfection of parasites
T. brucei 29-13 procyclic form parasites, which express T7 RNA polymerase as
well as the tetracycline repressor, were maintained in SDM-79 as described (19). PFPTS2-FP previously named pXS2-Aldo-PTS-eYFP (20) and PF-FP were maintained in
SDM-79 containing G418 (15µg/ml), hygromycin (50µg/ml) and blasticidin (15µg/ml).
Clonal cell lines were obtained by limiting dilution (~0.33 parasites/well) into 96 well
plates.

Generation of fluorescent reporter strains
To generate PF-FP parasites, the open reading frame of green fluorescent protein
(GFP) was cloned using the HindIII site into the pXS2 (21) (kind gift provided by J.
Bangs, University of Wisconsin) expression vector in which the neomycin resistance
gene was replaced with the blasticidin resistance gene (pXS2bla). This plasmid
integrates into the tubulin locus and constitutive expression is driven by the PARP
promoter. Orientation was confirmed by sequencing. PF parasites were stably
transfected as described (22) with 10 µg of the MluI linearized pXS2-FP construct and
selected by supplementing the growth media with 15 µg/mL blasticidin.
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Live cell microscopy
For analysis of fluorescence in live cells, parasites were collected by
centrifugation (800 x g, 10 min.) and washed once with PBS. Cell pellets were then
resuspended in vectashield mounting media (Vector laboratories, Burlingame, CA) and
visualized on a Zeiss Axiovert 200M using Axiovision software version 4.6.3 for image
analysis.

Transmission electron microscopy
For ultrastructural analysis, PF parasites were fixed in 2%
paraformaldehyde/2.5% glutaraldehyde in 100 mM phosphate buffer for 1 hr at room
temperature. Samples were washed in phosphate buffer and postfixed in 1% osmium
tetroxide (Polysciences Inc., Warrington, PA) for 1 hr. Samples were then rinsed
extensively in dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella
Inc., Redding, CA) for 1 hr. Following several rinses in dH20, samples were dehydrated
in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.).
Ultrathin sections of 90 nm were obtained with a Leica Ultracut UCT ultramicrotome
(Leica Microsystems Inc., Bannockburn, IL), stained with uranyl acetate and lead citrate,
and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA Inc.,
Peabody, MA) at the Molecular Microbiology Imaging Facility, Washington University
School of Medicine in St. Louis.
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Glycosome measurements
ImageJ software (http://rsb.info.nih.gov/ij/) was used to analyze electron
microscopy images of both bright and dim parasite populations. The area of cell visible
and individual glycosomes were measured for each image. To calculate glycosome
density, the total number of glycosomes was divided by the area of cell visible. This
value was then converted to glycosomes/100µm2. To calculate the percent of cell area
occupied by glycosomes, the area of all glycosomes was summed and divided by the area
of cell visible, for each image analyzed. These values were averaged for each population.
From the dim population, 13 images, containing 24 cells and 87 glycosomes were
analyzed. From the bright population, 13 images, 26 cells and 119 glycosomes were
analyzed.

Cytometric analysis, cell sorting and western blot analysis
Enhanced YFP fluorescence in live cells was monitored using either a BD
FACSCan flow cytometer, Accuri C6, or BD Influx cell sorter. Fluorescence emission at
530/540 nm (FITC channel) was collected after excitation with a 488 nm laser and data
were analyzed using FLOWJO software (TreeStar Inc., Ashland, OR). Cells were sorted
directly into SDM-79 using the BD Influx with a 100 micron tip at a sheath pressure of
12 psi and a drop frequency of 28.7 kHz and samples were processed for EM and western
analysis immediately. Cell viability after sorting was confirmed by microscopy and
estimated (by counting of live cells) to be > 90%.

For western blotting, cell lysates (5x

106-107 cells) were resolved by 12% SDS-PAGE and transferred to Protran
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nitrocellulose. Blots were processed as described in (23) and probed with the following
antibodies: TbHK (1:10,000), PFK (1:10,000), FPBase (1:10,000), triosephosphate
isomerase (TIM) (1:10,000), G6PDH (1:10,000), GK (1:10,000), PEX 13 (1:10,000),
which were provided by Paul Michels (de Duve Institute and Université catholique de
Louvain, Brussels (9)). Rabbit anti-glycosome antibodies (1:1000) 2841D were provided
by Marilyn Parsons ((24) SBRI). TbPEX11 (1:4,000) antibodies were provided by
Christine Clayton (14) (Universität Heidelberg, Heidelberg, Germany). Mouse anti-GFP
antibodies (1:1,000, Molecular Probes, Eugene, OR), were used to detect eYFP.

Analysis of environmentally-dependent changes in glycosome composition
Cells cultured for extended periods of time are diminished in their ability to
respond to environmental changes. Therefore, immediately after transformants emerge
from drug selection, stable cell lines are stored in freezing media (24mM KCl, 0.03 mM
CaCl2, 2 mM K2HPO4, 5 mM HEPES, 0.4 mM EDTA, 1 mM MgCl2 in 50% glycerol) in
LN2.

Before use, cells were thawed and seeded at a density of 1x105/ml. When cells

reached log-phase, ~6 x 106/ml, they were passed into fresh media to a final
concentration of 1 x 105/ml or 5 x 105/ml and analyzed by flow cytometry over 24 h.
Prior to each remodeling assay, cells were seeded to a density 1x105/ml and grown to logphase. After transformation, cells were passaged no more than twice after which they
were decontaminated and discarded and new cells are transformed.
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Results
Cytometric analysis reveals two cell populations that differ in their relative fluorescence.
We have previously generated a fluorescent glycosomal reporter system for use in
live cells by fusing the peroxisome targeting sequence 2 (PTS2) of aldolase, which
targets proteins to the glycosome (25), to the open reading frame of eYFP (FP). In this
cell line, PF-PTS2-FP (previously named 29-13-pXS2-Aldo-PTS-eYFP), constitutively
expressed PTS2-FP is targeted to glycosomes as indicated by fluorescence microscopy
(Fig. 2.1A and (20)).
Flow cytometry of PF-PTS2-FP cultures revealed two distinct populations (one
“bright” and one “dim”) that differed by almost two orders of magnitude in relative
fluorescence (Fig. 2.1B). This was in contrast to PF-FP cells expressing GFP lacking a
PTS2 signal sequence (PF-FP, Fig. 2.1B), which yielded a single peak. Both bright and
dim cell populations in the PF-PTS2-FP cultures excluded propidium iodide equally,
suggesting that viability was not compromised in the cells with reduced fluorescence
(data not shown). Four independent clonal cell lines obtained by two separate
transformations were analyzed and all contained both bright and dim populations, further
suggesting that the differences in expression were not due to unexpected integration
events or artifacts introduced via selection.
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Figure 2.1. Heterogeneous distribution of PF-PTS2-FP.
(A) PTS2-eYFP and GFP were cloned into the expression vector pXS2bla, a derivative of
pXS2 (2) in which the neomycin resistance gene has been replaced with the gene
encoding blasticidin resistance. The expression plasmid (image modified from reference
2) contains the procyclin promoter (gray box), the PARPba intergenic region (black
box), the Tubba intergenic region (white box), and the blasticidin resistance gene
(hatched box). Fluorescent PF-PTS2-FP cells were incubated with Lysotracker and
imaged by fluorescence microscopy. (B) Histograms of PF-PTS2-FP and PF-FP cultures.
Fluorescence at 530/540nm (FL1-FITC) was measured. A total of 10,000 events of each
population were analyzed.
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Cells of different fluorescent intensities differ in glycosome protein composition but have
similar glycosome morphologies.
To explore the absence of PTS2-FP in the dim cells and directly assess the
expression of other glycosomal proteins, both bright and dim populations were analyzed
by western blotting. Cells were sorted according to their relative fluorescence intensities
and sorting efficiencies were confirmed by cytometric analysis of the sorted populations
(Fig. 2.2A). Lysates from equal cell equivalents (5 x 105) of each population were then
analyzed by western blotting using antibodies that recognize eYFP, and antisera (2841D,
(24) that recognize the two glycosomal matrix proteins, aldolase and glyceraldehyde 3phosphate dehydrogenase (GAPDH). Notably, the cells from the dim population lacked
detectable levels of PTS2-FP, aldolase and GAPDH but expressed equivalent levels of
the surface protein, procyclin (Fig. 2.2B). Further western analysis was used to assess the
expression of other glycosomal proteins in bright and dim cells (Fig. 2.2C). Dim cells
expressed low or undetectable levels of TbHK, FPBase, TIM, G6PDH, and glycerol
kinase. Interestingly, TbPEX11, an integral glycosome protein was detected in dim cells,
while a protein essential to glycosome protein import, TbPEX13, is not detectable. These
findings suggest that dim cells harbor glycosomes but that they are not competent to
import matrix proteins.
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Figure 2.2. Western blot analysis of dim and bright cells.
PT-PTS2-FP cultures at 107/ml were analyzed by flow cytometry and sorted into two
populations based on their fluorescence in the FITC channel (530/540 nm). (A)
Histograms of initial presort population (top panel) and postsort analysis of 10,000 events
from the dim population (middle panel) and bright population (bottom panel) sorts. (B) A
total of 5x105 cell equivalents of each population were resolved by SDS-PAGE and
analyzed by Western blotting. Procyclin and a cross-reactive protein (control) were used
as loading controls. (C) Western analysis of lysates probed with antibodies against
glycosome resident proteins. Coomassie blue-stained protein is shown as a loading
control. HK, hexokinase; PFK, phosphofructokinase; FBPase, fructose 1,6bisphosphatase; TIM, triosephosphate isomerase; GK, glycerol kinase.
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We next used transmission electron microscopy to confirm the presence of
glycosomes in dim cells as well as analyze morphology of these organelles in the
different cell populations (Dim, Fig. 2.3A; Bright, Fig. 2.3B). In both bright and dim
cells, electron dense glycosomes were observed. There was no dramatic difference in
size, number or location of glycosomes in each of the populations. Bright cells had an
average of 112 glycosomes/100µm2 cell area (Fig. 2.3E), with an average area of
0.02µm2 (Fig. 2.3C) and made up 2% of the cell area (Fig. 2.3D). Average glycosome
number in dim cells was 119 cells/100µm2 (Fig. 2.3E), with an average area/glycosome
of 0.027µm2 (Fig. 2.3C) and comprised 2.43% of the area of the cell (Fig. 2.3D).

Cells of intermediate fluorescence are observed in low glucose media.
Dim cells have glycosomes, as demonstrated by EM. However, the lack of
TbPEX13 suggested that these glycosomes were not able to import glycosomal proteins.
It is known that the mislocalization of glycosomal proteins is lethal when cells are grown
in standard SMD-79 with glucose. We therefore hypothesized that cells harboring a large
number of immature glycosomes must repress glycosome protein expression under
standard culturing conditions. In the absence of glucose, the mislocalization of
glycosome proteins is less detrimental to the parasites and we reasoned that under these
conditions, cells of intermediate fluorescence would be detected. To test this, we grew
cells in low-glucose media (SDM-80), which was used previously to study how PF
metabolism changes in response to extracellular levels of glucose and proline (26), and
monitored fluorescence by flow cytometry (Fig. 2.4). Indeed, when cultures were grown
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in low-glucose conditions, cells of intermediate fluorescence were observed, resulting in
a single broad peak consisting of cells exhibiting a continuous range of fluorescence
intensities. Furthermore, addition of glucose (5mM) to SDM-80 restored the bimodal
population distribution indicating that glucose is the media component responsible for
these differences in glycosome composition (Fig. 2.4).

Figure 2.3. Transmission electron microscopy.
Fluorescence-activated cell sorting (FACS) was used to sort cultures based on their
fluorescence intensities. (A and B) Dim (A) and bright (B) cells were fixed and processed
for TEM as described in Materials and Methods. Arrows indicate glycosomes and
acidocalcisomes. Mitochondria (M) and kinetoplasts (K) are indicated. Scale bar=0.5µm.
The average area/glycosome (C), number of glycosomes/cell area (D), and percent cell
area comprised of glycosomes were calculated as described in Materials and Methods.
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Figure 2.4. Glycosome composition is regulated by extracellular glucose levels.
Cells were grown in SDM-79 (A), SDM-80 (B), and SDM-80 plus glucose (C) and
analyzed by flow cytometry. Side scatter (SSC) and fluorescence at 530/540 nm (FL1FITC) of 10,000 events were plotted.
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We next measured the rate at which this intermediate population changed in
response to different media conditions. Cells grown in SDM-80 were passed into SDM79 and analyzed by flow cytometry. A decrease in the number of intermediate cells was
observed at one hour and by 24h two distinct populations were observed. In contrast,
when cells were moved from SDM-79 into SDM-80, it took longer for the intermediate
population to appear (Fig. 2.5). By day 5 a continuous range of cells with varying levels
of fluorescence intensities was observed. Because cells harboring immature glycosomes
are so well resolved in SDM-79, we have chosen to use these conditions to study changes
in glycosome composition that occur in response to changing environmental conditions.

Changes in media conditions trigger changes in glycosome protein expression.
In yeast and mammalian cells, peroxisome turnover is triggered by changes in
media conditions (27). To test the effect that environmental changes have on glycosome
composition, we passed cells from a log-phase culture into fresh SDM-79 at a
concentration of 105/ml bright and dim measured populations by flow cytometry. When
cells were passed from log-phase culture to fresh media at a concentration of 1 x 105/ml,
the number of cells falling within the left gate (includes dim cells exhibiting background
fluorescence as well as cells of intermediate fluorescence) increased 3-fold with 30.1%
dim cells present at 3h post-passage (Fig. 2.6B) as opposed to 10.8% of cells in the left
gate in log-phase culture (Fig. 2.6A). By 24 h., the original population distribution was
restored (Fig. 2.6C). When cells were subjected to a less dramatic change in cell number
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and media conditions by passing them to a final concentration of 5 x 105/ml there was no
change in population distribution (Fig. 2.6D and E).

Figure 2.5. Kinetics of medium-dependent glycosome remodeling.
(A) Cells grown in SDM-80 were passed into SDM-79 and analyzed by flow cytometry.
(B) Cells grown in SDM-79 were passed into SDM-80. Side scatter (SSC) and
fluorescence at 530/540 nm (FL1-FITC) of 10,000 events were plotted.
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Figure 2.6. Passage into fresh medium triggers changes in glycosome composition.
Cells were passed from log-phase culture (A) to 1x105/ml (B and C) or 5x105/ml (D and
E) and analyzed by flow cytometry at 3h (B and D) and 24h (C and E). All cells were
passaged and grown in SDM-79. (F) Experiments were performed in triplicate and
averages and standard deviations of percent dim cells calculated.
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Discussion
We have generated a fluorescent glycosome reporter system in T. brucei that
allows us to quickly visualize glycosomes in large numbers of live cells under a variety
of different conditions. Using this system, we have identified two populations of PF
parasites in culture that harbor different glycosomes. This work reveals that PF
glycosome composition varies in an environmentally-dependent manner (Fig. 2.7).

Figure 2.7. Proposed model for glycosome dynamics in T. brucei.
In SDM-79, two parasite populations, one bright and one dim, are present. Dim cells
harbor a majority of immature glycosomes that are import incompetent and repress
glycosome protein expression. Bright cells harbor enough mature glycosomes to support
glycosome protein import. In low-glucose (SDM-80) medium, cells of intermediate
fluorescence are observed, presumably because under these conditions any potential
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cytosolic localization of glycosome proteins is tolerated. Dilution of log-phase cultures
into fresh medium triggers changes in glycosome composition, resulting in a transient
increase in dim parasites.

Dim cells express very little or undetectable levels of a number of glycosome
matrix proteins. TEM showed that dim cells do harbor glycosomes; a finding that is
consistent with the expression of the integral glycosome membrane protein, TbPEX11, in
these cells. These results, along with the absence of TbPEX13, a protein involved in
glycosome protein import, suggested that dim parasites harbor immature glycosomes that
are unable to import glycosome proteins. We propose that because these organelles are
import incompetent and because mislocalization of glycosomal proteins is lethal under
most conditions (12, 28), the expression of glycosomal proteins must be repressed until
enough mature organelles are present to correctly localize glycosomal matrix protein.
We hypothesize that this tight regulation of glycosome protein is responsible for the
bimodal population distribution observed in standard SDM-79 media. Consistent with
this hypothesis is the observation that when cells are grown in low-glucose conditions in
which the mislocalization of glycosome proteins is tolerated, cells with intermediate
fluorescence intensities are observed.
Several lines of evidence argue against the supposition that these observations are
a consequence of misregulated expression of recombinant fluorescent protein in a
transgenic system. First, it should be noted that the expression of cytosolic GFP from
the same expression vector (pXS2 derivative) yielded a single homogenous population,
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indicating that the bimodal population is likely not a consequence of unidentified
regulation signals in the expression constructs or integration into unanticipated sites in
the genome. Furthermore, the dim cells lack not only the PTS2-eYFP reporter, but also
aldolase and GAPDH as well as a number of other glycosome proteins. It is unlikely that
transformation and expression artifacts would affect expression of proteins other than
PTS2-FP.
De novo biogenesis of peroxisomes has been demonstrated in yeast and
mammalian cells ((29, 30). In this process, the sequential maturation of peroxisomes is
observed whereby pre-peroxisomal vesicles bud from the ER. In S. cerevisiae, the
peroxin, PEX3, was fused to yellow fluorescent protein and found to localize to immature
pre-peroxisomal vesicles which bud from the ER. The protein first localized to the ER
with another peroxin, PEX19. PEX3-PEX19 containing foci were then found to bud off
from the ER and newly formed peroxisomes capable of importing matrix proteins,
developed into mature glycosomes or fused with existing organelles (31). Another
example of the temporal regulation of peroxisome protein import is seen in the yeast
Hansenula polymorpha. In this model system, peroxisomes first grow by the
incorporation of lipids and proteins. After reaching a threshold size, the organelles give
rise to new ones through fission. The progenitor organelle is metabolically active, but no
longer capable of importing new protein (32, 33).

To our knowledge the presence of a

de novo biogenesis process or sequential glycosome maturation in T. brucei has never
been examined and to date, database analysis has failed to reveal a PEX3 homolog.
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We found that changes in glycosome composition occur rapidly in response to
changes in environmental conditions. Passage of cells from a log-phase culture to fresh
media triggered a transient increase in the percentage of “dim” cells that fell within the
left gate. This change was initiated within 3h and the original population distribution was
restored within 24h. We find that the manner in which the cells are cultured dramatically
affect their ability to respond to changes in the environment.

In some cases, this

increase in the “dim” population approached 100%, while cells cultured for long periods
of time become insensitive to changes in the environment (data not shown). To control
for this, cells used in remodeling assays are thawed from stabilates and seeded at 1
x105/ml and grown to a density of 6x106/ml before being passed into fresh media. Cells
used in the assays are not passed more than twice. We have found that these conditions
provide the most reproducible, although not always the most dramatic, results. Changes
in cellular metabolism as well as changes in media composition that occur during growth
in culture likely contribute to the variability of the cells response to changes in
environment. We are currently in the process of identifying and characterizing the effect
of different variables on changes in glycosome composition as we believe this is
important to understanding the biological relevance of such responses.
The time-frame of these changes in glycosome composition is consistent with the
process of autophagy. To date, we have not been able to demonstrate any effect of
autophagy inhibitors such as 3-methyladenine and wortmannin on remodeling. However,
it is difficult to determine if these compounds work to inhibit autophagy under our
experimental conditions. We are in the process of assessing the efficacy of such
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inhibitors in blocking autophagy under our conditions. Furthermore, we are using TEM
to assess the extent to which autophagic structures are formed during this remodeling
process.
Dilution of cells from a log-phase culture into fresh media changes the carbon
source availability and triggers a change in glycosome composition. Peroxisome
remodeling in response to environmental conditions is documented in a number of
organisms. For example, in S. cerevisiae, changes in peroxisome composition are
observed when cells are moved from an oleic acid based media to one in which glucose is
included as a carbon source (34). Under these conditions, the peroxisome matrix protein,
Fox3p, is degraded. In methanol media, the yeast Pichia pastoris has large, clustered
peroxisomes whereas small, diffused organelles are present when grown in oleic acid
(27). In another yeast, Hanensula polymorpha pexophagy is induced when cells are
moved from methanol to glucose media.
We observed a change in glycosome composition when cells were passed back to
1 x 105/ml but not when they were passed to 5 x 105/ml. At this point we do not know if
this change in glycosome composition is the result of changes in cell density or media
composition as the cells were not washed between passages. It is possible that the
residual media carried with cells through passage affected the cellular response.
Separating these two variable has been difficult as washing the cells before diluting them
to 1 x105/ml greatly reduces cell viability.
In T. brucei, it is possible that the two parasite populations have different
metabolic capacities. Parasites containing dim glycosomes lacking aldolase and GAPDH
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may rely heavily on amino acid metabolism and therefore do not require the large number
of glycolytic enzymes normally housed in the glycosome.
Additionally, de novo synthesized glycosomes may be primarily populated with
proteins carried from the ER, likely the source of origin. The lack of PEX13 may block
the import of metabolically important proteins and serve as a means to regulate maturity.
Further work on the protein composition and metabolic status of each population will be
required to address this model.
We do not know if glycosomes of BSF parasites exhibit the type of plasticity
observed in PF parasites. We predict that the obligate dependence on glucose
metabolism may prevent or repress dramatic changes in glycosome matrix protein
composition.
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Short Abstract
Glycosome dynamics in African trypanosomes are difficult to study by traditional cell
biology techniques such as electron and fluorescence microscopy. As a means of
observing dynamic organelle behavior, a fluorescent-organelle reporter system has been
used in conjunction with flow cytometry to monitor real-time glycosome dynamics in live
parasites.

Long Abstract
Trypanosoma brucei is a kinetoplastid parasite that causes human African
trypanosomiasis (HAT), or sleeping sickness, and a wasting disease, nagana, in cattle (1).
The parasite alternates between the bloodstream of the mammalian host and the tsetse fly
vector. The composition of many cellular organelles changes in response to these
different extracellular conditions (2-5).

Glycosomes are highly-specialized peroxisomes in which many of the enzymes involved
in glycolysis are compartmentalized. Glycosome composition changes in a
developmental and environmentally-regulated manner (4-11). Currently, the most
common techniques used to study glycosome dynamics are electron and fluorescence
microscopy; techniques that are expensive, time and labor intensive, and not easily
adapted to high-throughput analyses.
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To overcome these limitations, a fluorescent-glycosome reporter system in which
enhanced yellow fluorescent protein (eYFP) is fused to a peroxisome targeting sequence
(PTS2), which directs the fusion protein to glycosomes (12), has been established. Upon
import of the PTS2eYFP fusion protein, glycosomes become fluorescent. Organelle
degradation and recycling results in the loss of fluorescence that can be measured by flow
cytometry. Large numbers of cells (5,000 cells/sec) can be analyzed in real-time without
extensive sample preparation such as fixation and mounting. This method offers a rapid
way of detecting changes in organelle composition in response to fluctuating
environmental conditions.
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Introduction
Trypanosoma brucei causes African sleeping sickness in humans and a wasting
disease, nagana, in cattle. Drugs used in the treatment of these diseases are antiquated
and extremely toxic, vaccines are not available, and the potential for the development of
drug resistance necessitates the search for new drug targets (1).
During its life cycle, T. brucei, alternates between an insect vector and
mammalian host; two hosts that present very different environments in which the parasite
must survive. A number of metabolic and morphological changes occur as the parasite is
exposed to different environmental conditions. Some of the most dramatic changes are
observed in single-membrane-bounded parasite-specific microbodies, termed glycosomes
(13).
Glucose levels are relatively high (~5 mM) in the bloodstream and bloodstream
parasites (BSF) generate ATP exclusively through glycolysis while mitochondrial
metabolism is repressed (14). Unlike other eukaryotes in which glycolysis occurs in the
cytoplasm, T. brucei compartmentalizes most of the glycolytic enzymes in glycosomes
(14, 15). The parasites are taken up by the tsetse fly during a bloodmeal and experience a
drop in glucose, which falls to undetectable levels within 15 min of being ingested by the
fly. The metabolism of insect, procyclic form (PCF), parasites is more flexible and
glucose, as well as amino acids such as proline, can be used in the synthesis of ATP (1618). Comparative proteomic studies reveal life cycle dependent changes in glycosomal
and mitochondrial proteins with glycolytic proteins increased in bloodstream parasites
and mitochondrial proteins involved in TCA cycle and respiratory chain (13, 19). While
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many studies have focused on the differences between BSF and PCF glycosomes, little is
known about the changes in PCF glycosomes that occur in response to environmental
changes.
In the hindgut of the fly, glucose levels are low with transient increases during a
feeding (20). In most in vitro studies, PCF parasites are grown in media containing
glucose. However, recent studies have demonstrated that PCF metabolism changes
significantly in response to glucose availability (17). In the absence of glucose, proline
uptake and proline dehydrogenase activity increase (18). This change in mitochondrial
metabolism is likely accompanied by a change in glycosome composition and
morphology, however, this has not been directly assessed.
Electron and fluorescence microscopy are common techniques used to study
glycosome dynamics in T. brucei (2, 22-24). These protocols are time and laborintensive, expensive, and difficult to adapt to real-time studies and high-throughput
protocols. To overcome this limitation, a fluorescent-organelle reporter system used to
study organelles in mammalian and yeast systems has been modified for use in T. brucei
(12).
Fluorescent-organelle reporter systems have been extensively used in higher
eukaryotes such as yeast, plant, and mammalian cells (25-27). In such systems, a
fluorescent protein is fused to an amino acid sequence that targets the protein to specific
organelles. The degradation or synthesis of the targeted proteins is measured via
fluorescence and changes in organelle composition are reflected by changes in cell
fluorescence.
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When the open reading frame of enhanced yellow fluorescent protein (eYFP) is
fused to a type II peroxisomal targeting sequence (PTS2) (12) (Fig 3.1A), the PTS2eYFP
protein is imported into mature, import-competent glycosomes and fluorescence can be
monitored via flow cytometry (Fig 3.1B). Variations in glycosome composition are
reflected by changes in cellular fluorescence. This system can aid in resolving the
mechanisms that regulate environmentally-induced changes in glycosome composition.
This manuscript describes the generation of a glycosome reporter system in PCF
parasites in conjunction with flow cytometry to monitor real-time glycosome dynamics in
live parasites and provides an example of how it has been used to follow changes in
glycosome composition in response to different environments. In summary, glycosome
composition is influenced by extracellular glucose concentrations and passage of logphase cultures into fresh media triggers changes in glycosome composition. This system
can be modified to study the dynamic behavior of other organelles in trypanosomes and
other parasites.
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Figure 3.1: Fluorescent glycosome reporter system. A. PTS2eYFP expression
construct integration. PCF trypanosomes were transformed with the pXS2PTS2eYFP
plasmid linearized with the restriction enzyme MluI. This construct integrates via
homologous recombination into the tubulin locus (Tub) and PARP sequences (PARP)
includes the promoter that drives the constitutive expression of PTS2eYFP and the
sequences required for RNA processing. B. PTS2eYFP import. PTS2eYFP is
synthesized in the cytoplasm where it binds the soluble receptor, PEX7, which delivers
the reporter protein to the glycosomes. Once delivered to the glycosome membrane, the
protein is imported. Mature organelles containing import machinery import PTS2eYFP
and fluorescence while those that do not contain functional import machinery remain dim.
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Protocol
1. General trypanosome husbandry.
1.1)

Weigh solids for SDM79 media preparation (Table 1).

SDM79 solids
Graces insect cell media powder
Glucose
HEPES
MOPS
NaHCO3
Sodium pyruvate
L-alanine
L-arginine
L-glutamine
L-methonine
L-phenylalanine
L-proline
L-serine
L-taurine
L-threonine
L-tyrosine
Adenosine
Guanosine
Glucosamine HCl
Folic acid
r-aminobenzoic acid
biotin

Weight (g/L)
2
1
8
5
2
0.1
0.2
0.1
0.3
0.07
0.08
0.6
0.06
0.16
0.35
0.1
0.01
0.01
0.05
0.004
0.002
0.0002

Table 3.1: SDM79 solid components. Solid media components and amount (g/L) are
provided.

1.2)

Store at 4°C in 50 ml conical or a ziplock bag. Note: Reagents are stable for at

least 6 months.
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1.3)

Thaw fetal bovine serum (FBS) in a 37°C waterbath, and mix periodically by

inversion. Note: FBS is received from the supplier as a sterile solution. Filter sterilizing
FBS reduces its ability to support parasite growth.

1.4) Once the entire bottle is thawed, heat inactivate serum for 30 min in a 56°C
waterbath, mixing periodically to minimize precipitation of serum components.

1.5) Thaw penicillin/streptomycin solution (pen/strep), hemin (2 mg/ml in 50 mM
NaOH) and basal Medium eagle vitamin solution at room temperature.

1.6) To a 1000 ml graduated cylinder, add 20.2 g of SDM79 solids (Table 3.1) to the
liquid components (Table 3.2) and mix well on a stir plate.

SDM79
MEM with glutamine
Pen/Strep
BME vitamin solution
MEM amino acids solution
MEM non-essential amino acid solution
hemin
water

Volume (ml/L)
600 ml
10 ml
10 ml
8 ml
6 ml
3.75
162.25 ml

Table 3.2: SDM79 liquid components. Volumes ml/L are given.

1.7) Adjust pH to 7.35, and bring volume to 850 ml with water.
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1.8) Filter-sterilize media by attaching a vacuum hose to the bottom of a filter bottle.
Apply vacuum until the solution is filtered.

1.9) Remove filter top in the biosafety cabinet and add 150 ml of heat-inactivated FBS.
Remove plastic covering from sterile cap and seal media bottle.

1.10) Prepare SDM80 media in the same way as SDM79 with the following exceptions;
do not add glucose or glucosamine and use MEM without glutamine. In place of 150 ml
of heat inactivated FBS, add 135 ml of dialyzed, heat inactivated FBS and 15 ml of heat
inactivated FBS.

1.11) Culture PCF parasites in 25cm2 flask with 10 ml appropriate medium at 27°C and
5% CO2. Note: Cells should be counted daily using a hemocytometer or a flow cytometer
(see section 6) and cultures should be maintained at densities between 1 x 105 and 5 x 106
cells/ml.

2.

Transfection of PCF parasites with the fluorescent reporter construct.

Note: To follow glycosome dynamics, a reporter protein containing the peroxisomal
targeting sequence (PTS2) of aldolase fused to enhanced yellow fluorescent protein is
expressed in the parasites. The sequence encoding the fusion protein is cloned into
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pXS2bla (12), which contains the procyclin promoter, the tubulin ba intergenic regions,
which direct homologous recombination into the genome and the blasticidin resistance
gene for selection. Procyclic cell lines harboring the genes encoding the T7 polymerase
and tetracycline repressor (PF29-13) are transformed with the targeting construct,
pXS2:PTS2eYFP.

2.1) Prepare cytomix by mixing the components listed in Table 3.3. Filter sterilize and
store at RT.

cytomix
120 mM KCl
0.15 mM CaCl2
10 mM K2HPO4
25 mM HEPES
2 mM EDTA
5 mM MgCl2
water

For 20 ml
1.4 ml (1M)
3 µl (1M)
400 µl (0.5M)
500 µl (1 M)
80 µl (0.5M)
100 µl (1M)
16.52

Table 3.3: Cytomix recipe.

2.2) Linearize plasmid DNA with MluI by pipetting 10 µl of DNA (1 µg/µl), 5 µl
restriction enzyme buffer, 33 µl water and 2 µl of MluI enzyme into a microcentrifuge
tube. Incubate at 37°C for 1 hr.
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2.3) Purify the restriction digest by adding 1 volume of binding buffer to the restriction
enzyme digest. Mix binding buffer and digested DNA by vortexing. Briefly centrifuge to
collect the sample at the bottom of the tube.

2.4) Insert a DNA binding column into a 2 ml collection tube, and transfer digested
DNA/binding buffer solution to column.

2.5) Centrifuge for 10,000 x g for 1 min. After centrifugation, discard filtrate from
collection tube and return the column to the collection tube.

2.6) Add 700µl of SPW wash buffer and centrifuge at 10,000 x g for 1 min.

2.7) Discard filtrate from collection tube, return the column to the collection tube and
repeat SPW wash step and centrifugation.

2.8) Discard filtrate, return column to collection tube, and centrifuge empty column for
3 min at 10,000 x g to remove residual ethanol.

2.9) In biosafety cabinet, throw away collection tube and place column in a sterile
microcentrifuge tube.
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2.10) To elute the DNA, add 25µl of sterile water to column and incubate at room
temperature for 2 min. Centrifuge at 10,000 x g for 1 min.

2.11) Add another 25µl of sterile water in biosafety hood to column and incubate at
room temperature for 2 min.

2.12) Centrifuge at 10,000 x g speed for 1 min.

2.13) In a biosafety cabinet transfer entire volume of DNA to a new sterile
microcentrifuge tube. Note: This step prevents contamination from the open lid during
centrifugation.

2.14) Add the sterile, purified, linearized DNA (10µg) to 400µl of filter-sterilized
cytomix.

2.15) Count cells as described in section 6 and harvest 5 x107-108 cells by centrifugation
at 800 x g for 15 min. at RT.

2.16) Pour off supernatant and resuspend the cell pellet in 450µl of DNA + cytomix
using a 1ml serological pipette.
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2.17) Transfer solution containing cells, DNA and cytomix to a sterile 4 mm gap cuvette
and place cuvette in the electroporation chamber.

2.18) Select “Exponential decay” and manually enter the following settings: Voltage:
1.5kV, Capacitance: 25mF, Resistance: Ω, and Cuvette: 4 mm. Press pulse. Once the
pulse in complete, remove cuvette from the electroporation chamber and return to the
biosafety cabinet.

2.19) Into a new sterile flask, pipette 10 ml of SDM79. Transfer the transformed cells to
the flask with 10 ml of SDM79.

2.20) Incubate WITHOUT drug selection for 24 hr at 27°C, 5% CO2. After 24 hr, add
G418 (15µg/ml), hygromycin (50µg/ml) and blasticidin (10µg/ml). Pass 1ml of
transformed cells with drug into 9ml of SDM79 with drug.

2.21) Analyze cells daily as described in sections 6 and 7. When cells are fluorescent,
and have reached a cell density of 1 x 107/ml, make stabilates for long-term storage (3.13.3).

3. Making stabilates
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3.1) To make freezing media, add an equal volume of 100% glycerol to cytomix and
filter sterilize.

3.2) Add 200µl of freezing media to 800µl of cells (1 x 107) in a cryovial, mix gently by
inversion and place between two styrofoam racks and freeze at -80°C.

3.3) Once frozen (~ 24 h), transfer cells to liquid nitrogen. Note: It is important to move
cells into LN2 after 24 h, as longer storage at -80°C leads to a decrease in cell viability.

4. Thawing frozen stocks

4.1) Remove frozen vial from -80°C and thaw at RT for approximately 10 min.

4.2) Pipette 9 ml of SDM79 with drug into a new sterile flask. Add thawed cells to this
flask. Pass cells 1:10 by adding 1ml of this culture to 9ml of SDM79 in a new flask (final
concentration of 1 x 105/ml).

4.3) Before the cells reach a density of 107/ml, begin cytometer setup and dilution assays.
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5. Cytometer setup

5.1) Turn on the flow cytometer and open CFlow Plus program. Note: Before running
any samples, the fluidics should be backflushed and rinsed according to steps 5.1-5.9.

5.3) Replace the tube of nanopure water in which the sip is stored with an empty tube.

5.4) Select the “backflush” button.

5.5) Once backflush is complete, remove microcentrifuge tube from sip and discard.

5.6) Place a new microcentrifuge tube containing 1ml of new nanopure water on the sip.

5.7) Select a new well in CFlow program. Under “Run Limits” set time for 2 minutes.
Under “Fluidics” select “fast” and “Run”.

5.8) Once the 2 min time limit is complete, click the “Delete Sample Data” button.

6. Cell Counting using the flow cytometer

6.1) Replace water with the sample to be counted. Set “Run Limits” to 30 seconds,
“Fluidics” to “fast” and then select “Run”.
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6.2) After the 30 second time limit is complete, CFlow plus will provide the events/µl
under “Last Run.” Repeat count for each culture. Note: Before cells reach 1 x107 cells/ml,
proceed with dilution assay. Cells should be discontinued after one dilution assay is
completed. Cells cultured for longer periods lose their ability to respond to
environmental conditions.

7. Measuring fluorescence using the flow cytometer

7.1) To assess fluorescence, set “Run Limits” to 10,000 events, and “Fluidics” to
“slow”. Select “Set threshold”. Under “Primary Threshold”, select “Permanently
eliminate events on”, “FSC-H” (in drop down box) and enter less than 30,000. Click
“apply”, then “close”.

7.2) Select the “Histogram” button in one of the new plot windows and select “FSC-A”
From the drop down list, select “FL1-A”. Note: FL1-A measures fluorescence in the 530
nm wavelength.

7.3) Select “Run” and repeat for all cultures.

5.14) Run cleaning solution through the fluidics line for 2 min and water for 2 min.
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6. Dilution assays

6.1) Pass cells to a density of 1x105 cells/ml in 3 ml of SDM79 in a 25 cm2 culture flask
and measure florescence immediately after passage and then at 3 h and 24 h.

7. Data analysis

7.1) Select “Analyze” tab on CFlow Plus.

7.2) Click “Histogram” button under “Make a new plot.” Select “FSC-A” and a drop
down list will appear. Select channel “FL1-A.”

6.5) Highlight a well to analyze. Select “Gate” button, and manually draw a gate for the
population of interest.

6.7) CFlow Plus will provide cell “Count” within this gate and “% of This Plot”.

Representative results
In this system, a glucose-dependent change in glycosome composition was
observed. When cells are grown in glucose containing media, two populations are
observed; one bright and one dim (Fig. 3.2A). Dim cells harbor immature glycosomes,
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which have not imported the PTS2eYFP while bright cells harbor a mixture of mature
and immature glycosomes (12). When glucose is present in the media, mislocalization of
glycosome proteins is lethal (15, 28) and glycosome protein expression is likely coupled
closely with import. This tight regulation is responsible for the appearance of dim cells in
which glycosome protein expression is suppressed when the cells lack sufficient import
capability. Once the glycosome import machinery is fully assembled and functional, the
cells express glycosome proteins, which are then imported into glycosomes, yielding
fluorescent cells. In glucose-deplete media, the mislocalization of glycosome proteins is
tolerated (15), and the bimodal population distribution is replaced by a single peak with a
broader range of fluorescence (Fig. 3.2B).
This system has been used to identify conditions that trigger changes in
glycosome composition. When high density cultures containing ~10% dim cells (Fig.
3.3A) are passed into fresh media, there is a transient increase in the percentage of dim
cells (Fig. 3.3B). By 24 hr. the original population distribution is re-established (Fig.
3.3C).
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Figure 3.2. Glucose-dependent glycosome composition. PCF cells were grown in
SDM79 (+Glc) or SDM80 (-Glc) and analyzed by flow cytometry. Histograms of 10,000
events. A. Analysis of cells grown in SDM79 consistently reveals two peaks.
Fluorescent cells harbor a mixture of mature and immature organelles with cells of higher
fluorescence intensities having more mature glycosomes. In SDM79, mislocalization of
glycosome proteins is lethal and glycosome protein expression and import must be tightly
controlled. This is reflected in the absence of cells with intermediate fluorescence
intensities. B. In SDM80, the mislocalization of glycosome proteins is tolerated, the
bimodal population distribution is lost, and cells of intermediate fluorescence are
observed.
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Figure 3.3. Glycosome remodeling. Remodeling of glycosomes is triggered by passage
into fresh media. A. Histogram of 10,000 events in the starting culture (~4 x 106/ml). B.
Three hours after dilution into fresh SDM79 there is an increase in the proportion of dim
cells with immature glycosomes falling within the left gate. C. Histogram of the diluted
culture after 24hr. After 24 hr, the population distribution has returned to normal, as the
immature glycosomes now contain the peroxisome proteins necessary to import the
fluorescent protein.

Discussion
Glycosomes are essential, dynamic, parasite-specific organelles. The processes
that regulate the biogenesis, maintenance, proliferation and remodeling of these
organelles likely include drug targets that could be exploited for therapeutic purposes.
Despite the potentially high abundance of such drug targets, the field of glycosome
biogenesis has lagged behind the study of similar processes in other organisms,
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predominately due to the lack of a tractable, high-throughput system by which to monitor
rapid, dynamic, organelle responses in live cells.
Fluorescent-organelle reporter systems have been used to study organelle
dynamics in higher eukaryotes such as yeast, plants, fungi and mammals (23-25). We
have generated a transgenic strain of PCF parasites that express PTS2eYFP that is
targeted to mature glycosomes, yielding fluorescent organelles. Changes in glycosome
composition can be monitored via following cellular fluorescence. Using this system, we
have found that environmental conditions, notably glucose, regulate glycosome
composition (12).
In contrast to microscopy methods often used to study organelle dynamics in
kinetoplastid parasites, this reporter system offers a method by which to rapidly screen
compounds and conditions that influence overall glycosome dynamics. However, the
changes in fluorescence reflect changes in overall organelle compositions. Further
biochemical and microscopic experiments are required to define the specific molecular
differences between cell populations exhibiting different fluorescence intensities.
We have identified a number of critical steps in the remodeling assays.
Interestingly, we have found that as the cells are cultured for longer periods (more than
two passes), their behavior in response to environmental changes is unpredictable. After
prolonged culturing, cells passed from high densities into fresh media, exhibit a
temporary increase in the dim population, indicating that they are still able to remodel
glycosomes, but die after 24 hr. We have also encountered situations where no
remodeling is observed. The reason for this behavior is unclear but we have found that
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when cells are handled as described here (limiting the number of cell passages to two and
maintaining cultures below 1 x 107/ml), glycosome remodeling is reproducible. When
cells are no longer responsive to environmental conditions, re-transforming cells with the
reporter-construct plasmid usually remedies this situation.
While this system has been used to study glycosome behavior in African
trypanosomes, it can also be adopted to the study of organelles in other parasites by
fusing fluorescent proteins to amino acid sequences that direct protein localization to
other cellular compartments.
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Abstract
Trypanosoma brucei is the causative agent of diseases that affect 30,000-50,000 people
annually. T. brucei harbors unique organelles named glycosomes that are essential to
parasite survival, which requires growth under fluctuating environmental conditions. The
mechanisms that govern the biogenesis of these organelles are poorly understood.
Glycosomes are evolutionarily related to peroxisomes, which can proliferate de novo
from the endoplasmic reticulum or through the growth and division of existing organelles
depending on the organism and environmental conditions. The effect of environment on
glycosome biogenesis is unknown. Here we demonstrate that the glycosome membrane
protein, TbPex13.1, is localized to glycosomes when cells are cultured under high
glucose conditions and to the endoplasmic reticulum in low glucose conditions. This
localization in low glucose was dependent on the presence of a C-terminal tripeptide
sequence. Our findings suggest that glycosome biogenesis is influenced by extracellular
glucose levels and adds to the growing body of evidence that de novo glycosome
biogenesis occurs in trypanosomes. Because the movement of peroxisomal membrane
proteins is a hallmark of ER-dependent peroxisome biogenesis, TbPex13.1 may be a
useful marker for the study such processes in trypanosomes.
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Introduction
Trypanosoma brucei is a flagellated protozoan parasite that causes human African
trypanosomiasis (HAT) and a wasting disease in cattle called nagana (1). Parasite
infection is lethal without treatment and current therapies are toxic and difficult to
administer, making the search for new drug targets critical.
Trypanosomes have essential membrane-bounded organelles called glycosomes
that have been identified as good drug candidates (2, 3). Glycosomes lack DNA, import
proteins post-translationally, and are evolutionarily related to peroxisomes found in
higher eukaryotes as evidenced by the conservation in protein import machinery. The
mechanisms of glycosome biogenesis are not fully understood, although comparison of
components required for peroxisome biosynthesis has been useful in resolving potential
contributing proteins (4, 5). For example, homologs of 10 of the more than 58 described
eukaryotic peroxin (Pex) proteins have been identified in T. brucei. These proteins,
which regulate peroxisome biogenesis in yeast, mammals, and plants are essential to
parasites grown under standard conditions (5–15).
Peroxisomes are ubiquitous organelles found in most eukaryotic organisms (16).
They are functionally diverse and their composition varies with cell type and
environment. Reflecting this, a number of different metabolic pathway components are
contained within peroxisomes including enzymes involved in fatty acid catabolism, the
pentose phosphate pathway, and reduction of reactive oxygen species. Glycosomes
harbor similar pathways, but the trypanosome uniquely compartmentalizes most of
glycolysis in the organelle as well (3).
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The processes that regulate peroxisome biogenesis and maintenance have been
studied in yeast, plants, and mammals and include organelle proliferation, posttranslational protein import, and organelle specific degradation via pexophagy (17).
Protein import has been relatively well studied in trypanosomes (4) and glycosome
turnover via organelle specific autophagy, pexophagy, has also been documented (18,
19). In contrast, very little is known about glycosome biogenesis.
In higher eukaryotes peroxisome proliferation occurs via the growth and division
of existing organelles as well as de novo biogenesis via the endoplasmic reticulum (ER)
(16, 20, 21). In the growth and division of existing organelles, peroxisomes grow through
the incorporation of lipids from the ER followed by constriction and eventual fusion of
the peroxisome membrane. ER-dependent peroxisome biogenesis involves
preperoxisomal vesicles (PPV) that bud from the ER and mature via sequential protein
import of peroxisomal membrane and matrix proteins or fusion with other PPVs. The
degree to which each biogenesis mechanism occurs in wild-type cells is debated but
likely differs with organism, cell type and environment.
To date, ER-dependent glycosome proliferation has not been directly
demonstrated in trypanosomes. However, recent proteomic studies suggest that one
glycosome biogenesis protein, TbPex13.1, is in vesicles also containing ER proteins (22).
In other eukaryotes, Pex13 forms part of the membrane channel that facilitates posttranslational import of peroxisomal matrix proteins (23). In addition to its role at the
peroxisome membrane, this protein is also found in the ER (24). It has been proposed
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that ER-localized Pex13 may play a role in ER-dependent peroxisomal biogenesis
through mechanisms that are unclear.
While higher eukaryotes harbor a single Pex13, T. brucei, has two Pex13
homologs, TbPex13.1 and 13.2 (7, 13, 14). TbPex13.1 has a unique C-terminal
peroxisomal targeting sequence type 1 (PTS1) sequence that is typically found on
peroxisome matrix proteins. This sequence is usually recognized by the soluble receptor
Pex5, which delivers the cargo to the peroxisome membrane for matrix localization.
Peroxisomal membrane proteins (PMPs), however, are usually delivered to the
peroxisome by the cytosolic chaperone Pex19 (25). Because TbPex13.1 harbors a
putative Pex19 binding domain and a PTS1, the targeting of the protein is enigmatic.
These two Pex13s are also found in other kinetoplastids including Trypanosoma cruzi,
Leishmania and Crithidia.
T. brucei experiences fluctuating extracellular glucose levels during the life cycle
as it alternates between the mammalian bloodstream and the tsetse fly vector (1, 26). In
the mammalian host, bloodstream form (BSF) parasites are exposed to relatively high
glucose levels (~5 mM), while the insect or procyclic form (PCF) of the parasite spends
most of its time in glucose poor conditions. While the parasites are exposed to changing
nutrient availability in their natural environment, both BSF and PCF parasites are
routinely cultured in media containing 5mM glucose. In other eukaryotes, peroxisome
composition and biogenesis are influenced by environmental conditions such as nutrient
availability (27). In trypanosomes, glycosome metabolism and the requirement for
glycosomal protein import vary with extracellular glucose levels (8, 28) and
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compartmentalization of glycolytic enzymes is essential at high extracellular glucose
levels (8, 29, 30). Here, we describe the localization of the glycosome membrane
protein, TbPex13.1, in PCF parasites grown under low glucose conditions.

Materials and Methods
Generation and transfection of epitope tagged TbPex13.1 and epitope tagged truncation
variants
The DNA sequence encoding an HA epitope tag (YPYDVPDYA) was fused to
the 5’ end of different TbPex13.1 variants, which included the full-length open reading
frame of TbPex13.1 (HATbPEX13.1), the TbPex13.1 gene in which the nucleotides (9731150) encoding amino acids 325-384 of the SH3 domain were deleted
(HATbPex13.1DSH3), and the TbPex13.1 gene in which the nucleotides encoding the Cterminal tripeptide SKL were deleted (HATbPex13.1DPTS). These fusions were cloned
into the vector pXS2 (31), which integrates into the tubulin locus and directs constitutive
expression by the procyclic acidic repetitive protein (PARP) promoter. After
confirmation by sequencing, plasmids were linearized with Mlu1 and T. brucei brucei
procyclic form (PCF) 29-13s (32) were transfected as previously described (33) using a
Bio-Rad Gene Pulser Xcell (Exponential, 1500V, 25µF, 4mm cuvette). Stably
transfected cells were selected by culturing in media containing 15 µg/ml blasticidin.
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Growth of parasites
PCF 29-13 cells were grown in SDM79 (5 mM glucose) or SDM80 (< 0.5 mM
glucose, 5.3 mM proline) (30) as previously described (34). PCF 29-13s expressing
HATbPex13.1, HATbPex13.1DSH3 or HATbPex13.1DPTS1 were maintained in either
SDM79 or SDM80 containing hygromycin (50 µg /ml), G418 (15 µg /ml), and blasticidin
(15 µg /ml).

Glycosome isolation and western blot analysis
Glycosomes were isolated via density centrifugation of glycosome rich postnuclear fractions over an Optiprep gradient (Sigma Aldrich, St. Louis, MO) as described
previously (35). Fractions (1 ml) were collected from the bottom of the gradient, protein
concentration determined by Bradford assay (Pierce, Life Technologies, Grand Island,
NY), and samples processed by acetone precipitation. Briefly, four volumes of ice cold
acetone was added to each fraction, vortexed, and incubated at -20 °C for 1 h.
Afterwards, fractions were centrifuged at 15,000g for 10 min, the supernatant decanted,
2.5 µg of each fraction resolved by SDS-PAGE, and probed with antibodies against the
glycosome proteins aldolase (1:20,000), hexokinase (1:100,000), and TbPex13.1
(1:10,000) which were provided by Dr. Paul Michels (de Duve Institute and Universite
Catholique de Louvain, Brussels, Belgium) (13), TbPex11 (1:4,000) provided by Dr.
Christine Clayton (Zentrum für Molekulare Biologie der Universität Heidelberg,
Germany) (36), and TbBiP (1:100,000) provided by Dr. Jay Bangs (University at Buffalo,
Buffalo, NY) (31).
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Immunofluorescence Microscopy
Immunofluorescence assay (IFA) conditions were modified from that previously
described by (37). Cells were harvested at 800g for 5 min and resuspended in fresh
media. Paraformaldehyde (1%) was added to cells and incubated on ice for 5 min. Cells
were then washed in ice cold Voorheis’s modified PBS (vPBS;10 mM glucose, 46 mM
sucrose, 3 mM NaCl, 3 mM KCl, 3 mM KH2PO4, 16 mM Na2HPO4, 137 mM NaCl, pH
7.6), incubated on poly-L-lysine slides for 20 min, and permeabilized with 0.1% Triton
X-100 in PBS. Slides were washed with vPBS and block (0.25% Tween in 1X vPBS)
applied. Primary mouse anti-HA (H9658) (Sigma-Aldrich, St. Louis, MO) was used to
determine the localization of HATbPex13.1 variants. Rabbit anti-aldolase and rabbit
anti-BiP were used as glycosomal and ER markers, respectively. Alexa Fluor 488conjugated goat anti-rabbit and Alexa Fluor 568-conjugated goat anti-mouse antibodies
(Life Technologies, Grand Island, NY) were used to detect primary antibodies. Slides
were mounted with vectashield containing DAPI (Vector Laboratories, Youngstown,
OH) and visualized on a Zeiss Axiovert 200M using AxioVision software version 4.8.2
for image analysis.

Results
TbPex13.1 localizes extraglycosomally in low glucose conditions
Glycosomes and other organelles such as ER and mitochondria can be isolated via
density centrifugation (35). We utilized this protocol to examine glycosome composition
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under high and low glucose conditions. In agreement with published data (7, 11, 13), the
glycosome matrix proteins aldolase and hexokinase and the peroxisome membrane
proteins TbPex11 and TbPex13.1 were all detected in fractions 14-22 when cells were
grown in high glucose media (Fig. 4.1A, left panel). Interestingly, when cells were
grown in low glucose media, TbPex13.1 was no longer detected in fractions harboring
other glycosome-resident proteins (Fig. 4.1A right panel). Instead, the protein was found
in higher fractions (26-30), which also contained the ER resident protein BiP.

Figure 4.1. TbPex13.1 localizes with ER marker proteins in density gradient and has
multiple domains. A. PCF parasites were grown in high glucose SDM79 (5 mM
glucose) or low glucose SDM80 (< 0.5 mM glucose). Post-nuclear supernatant was
resolved by density centrifugation over an Optiprep gradient. One ml fractions were
collected from the bottom of the gradient, and 2.5µg protein from each fraction was
resolved by SDS-PAGE and assayed by western blotting with antibodies that recognize,
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aldolase (TbAldo), TbPEX11, hexokinase (TbHK) and TbPex13.1 as well as the ER
resident protein TbBiP. B. TbPex13.1 has multiple structural domains. TbPex13.1
contains an YG-rich region, two transmembrane domains (hatched rectangles), a Pex19
binding sequence (grey oval), an SH3 domain and a PTS1 sequence (black rectangle).

TbPex13.1 has a unique domain structure
In contrast to higher eukaryotes that have a single Pex13 gene, T. brucei has two
Pex13 genes, TbPex13.1 and TbPex13.2 (7). Both are expressed and silencing of either
gene slows parasite growth and results in glycosome protein import defects. It is
unknown why trypanosomes have two Pex13s while higher eukaryotes have only one.
One unique aspect of the TbPex13.1 predicted protein sequence is the presence of a Cterminal peroxisome targeting sequence 1 (PTS1) (Fig. 4.1B). PTS1 sequences target
soluble matrix proteins to peroxisomes and glycosomes through binding with the soluble
receptor protein Pex5. This mechanism of targeting is distinct from that of peroxisomal
membrane proteins such as Pex13 that have two TM domains and a chaperone binding
site. These peroxisome membrane proteins (PMPs) are delivered to the peroxisome
membrane through the action of the soluble chaperone, Pex19 (25). Because TbPex13.1
harbors a putative TbPex19 binding sequence, we predict it to traffic to glycosomes in a
TbPex19-dependent process. Therefore, the presence of a PTS1-like sequence is
intriguing and its function is unclear.

90

Glycosome and ER morphology is maintained in low glucose conditions
We used indirect immunofluorescence assays to determine if ER or glycosome
morphology was altered in low glucose conditions. Cells grown in high glucose or low
glucose media were fixed and stained with antibodies against the ER marker, BiP, or the
glycosome marker protein, aldolase. Under both conditions aldolase staining was
observed in punctate structures that were distributed throughout the cells (Fig. 4.2A) as is
typically observed with T. brucei glycosomes (13). Additionally, BiP localization did not
change with extracellular glucose levels. In both high and low conditions, BiP antibodies
labeled tubular structures (Fig. 4.2B) consistent with ER (38).

HATbPex13.1 localizes to glycosomes when cells are grown in high glucose conditions
Because our TbPex13.1 antibodies do not work under immunofluorescence assay
(IFA) conditions, we fused an HA epitope tag to the N-terminus of TbPex13.1 and
followed the cellular localization of HATbPex13.1 in high and low glucose. In
agreement with previous reports from cells grown in high glucose (13) and our
fractionation experiments (Fig. 4.1A), HATbPex13.1 localized to punctate structures
distributed throughout the cytoplasm in a pattern that largely overlapped with the
glycosome-resident protein aldolase (Fig. 4.3A). Cells expressing HATbPex13.1 were
also stained with antibodies against the ER protein BiP, which labeled reticular structures
typical of ER staining (Fig. 4.3B). Under these high glucose conditions, HATbPex13.1
staining exhibits more overlap with glycosomal aldolase than with ER localized BiP.
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Figure 4.2. Glycosome and ER morphology is maintained in low glucose conditions.
A. Cells were grown in SDM79 or SDM80, fixed, permeabilized and stained with
antibodies against the glycosome protein, aldolase. B. Cells were grown in SDM79 or
SDM80, fixed, permeabilized and stained with antibodies against the ER protein, BiP.
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Figure 4.3. HATbPex13.1 localizes to glycosomes in SDM79 glucose rich media.
PCF parasites expressing HATbPex13.1 were, fixed permeabilized and stained with
mouse anti-HA antibodies, which were detected with Alexa Fluor 568-conjugated goat
anti-mouse antibodies and rabbit anti-aldolase or rabbit anti-BiP which were detected
with Alexa Fluor 488-conjugated goat anti-rabbit antibodies. A. Cells labeled with
HATbPex13.1 (red) and aldolase (green). B. Cells labeled with HATbPex13.1 (red) and
BiP (green).
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Cells expressing HATbPex13.1 have altered glycosome and ER morphology under low
glucose conditions
When cells were grown in low glucose media HATbPex13.1 staining was no
longer found in punctate structures distributed evenly throughout the cells but rather was
detected in larger foci concentrated within discrete regions of the cell (Fig. 4.4). To
assess glycosome morphology, we stained these cells with antibodies against aldolase.
Interestingly, aldolase staining was also altered in these cells under low glucose
conditions and exhibited a staining pattern very similar to that observed with anti-HA
antibodies (Fig. 4.4A). Because Pex13s localize to the ER in other systems, we assessed
BiP localization in these cells. Like aldolase and HATbPex13.1, BiP staining exhibited
glucose dependent localization. In low glucose conditions, BiP staining was no longer
reticular but contained within discrete areas of the cell that labeled with antibodies that
recognize HATbPex13.1 and aldolase (Fig. 4.4B).

Deletion of the SH3 domain does not alter localization
SH3 domains mediate protein-protein interactions. To assess the contribution of
this domain to the glucose dependent localization of HATbPex13.1, we performed IFA
on cells expressing the HATbPex13.1 in which the SH3 domain was deleted
(HATbPex13.1DSH3). Staining of the HATbPex13.1DSH3 variant was the same as
observed with the HATbPex13.1 (Fig. 4.4 and Fig. 4.5). In high glucose
HATbPex13.1DSH3 was detected in glycosomes and the anti-HA staining overlapped to
a greater extent with aldolase than with the ER marker BiP (Fig. 4.5A). In low glucose,
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however, HATbPex13.1DSH3 staining was restricted to foci that also stained with
aldolase and BiP (Fig. 4.5B).

Figure 4.4. HATbPex13.1 cells have altered glycosome and ER morphology when
grown in SDM80 low glucose media. A. HATbPex13.1 cells were fixed,
permeabilized and labeled with mouse anti-HA antibodies detected with Alexa Fluor
568-conjugated goat anti-mouse and rabbit anti-aldolase antibodies detected with Alexa
Fluor 488-conjugated goat anti-rabbit antibodies. B. HATbPex13.1 cells were fixed,
permeabilized and labeled with mouse anti-HA antibodies detected with Alexa Fluor
568-conjugated goat anti-mouse and rabbit anti-BiP antibodies detected with Alexa Fluor
488-conjugated goat anti-rabbit antibodies.
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The PTS1 domain is necessary for ER localization of HATbPex13.1 in low glucose
conditions
TbPex13.1 is unique in that it harbors a PTS1 sequence that is not present in
Pex13 sequences of other eukaryotes. To assess its role in the localization of
HATbPex13.1 we performed IFA on cells in which the PTS1 was deleted
(HATbPex13.1DPTS1). In contrast to HATbPex13.1 and HATbPex13.1DSH3,
HATbPex13.1DPTS1 localized to glycosomes under both high and low glucose
conditions (Fig. 4.6). Under both conditions anti-HA antibodies labeled punctate
structures containing aldolase and did not label reticular structures recognized by antiBiP antibodies. In all cases, HA staining overlapped more with aldolase than BiP.
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Figure 4.5. Deletion of the SH3 domain does not alter the glucose dependent
localization of HAPex13.1. A. Cells grown in SDM79 were stained for HATbPex13.1
(red) and aldolase (green). B. Cells grown in SDM80 were stained for HATbPex13.1
(red) and aldolase (green).
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Figure 4.6. HATbPex13.1DPTS localizes to glycosomes in high and low glucose
conditions. A. Cells grown in SDM79 were stained for HAPex13.1DPTS (red) and
aldolase (green). B. Cells grown in SDM80 were stained for HAPex13.1DPTS (red) and
aldolase (green).
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Discussion
Glycosomes are highly specialized peroxisomes found only in kinetoplastid
parasites (39–42). Because of their essential nature they have been identified as good
drug candidates. Peroxisome maintenance has been studied in yeast, mammals, and plants
and involves the coordination of peroxisome protein import, organelle biogenesis and
organelle degradation (16). Each process is governed by a set of proteins called peroxins
(Pex). Approximately 17% of the 58 PEX genes identified in yeast, mammals, and plants
have been identified in the trypanosome genome databases. Highlighting the importance
of these organelles, the silencing of any of these PEX genes is lethal in T. brucei grown
under standard conditions (5–15).
The overall mechanism of protein import into glycosomes appears to be
conserved with higher eukaryotes (4). In contrast, very little is known about the
mechanisms that regulate glycosome biogenesis. In yeast and mammalian cells,
peroxisome proliferation is a balance between the growth and division of existing
organelles or de novo biogenesis (17).
The extent to which each proliferation pathway predominates varies with
organism, cell type, life cycle stage, and environmental regulation (17). In yeast,
peroxisomes are usually formed by fission of existing organelles (43) except when cells
are temporarily depleted of peroxisomes through deletion of PEX genes essential for
peroxisome biogenesis (44, 45). In the absence of existing peroxisomes, yeast can
synthesize them de novo upon reintroduction of the deleted Pex gene. In mammalian
cells it has been proposed that peroxisomes multiply predominately through the de novo
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pathway (46). Recent studies suggest that glycosomes may be formed de novo in the
African trypanosomes. First, ER proteins have been identified in membrane vesicles
harboring GFPTbPex13.1 fusions (22). Additionally, a Pex16 homolog was recently
identified in T. brucei and silencing of this glycosome protein results in glycosome
abnormalities with accumulation of structures in the anterior part of the cells where ER
exit sites are located (5).
T. brucei encounters a number of different environmental conditions as it
alternates between the mammalian bloodstream and the insect vector (1). In the
mammalian bloodstream, glucose levels are present at relatively constant and high levels
(~ 5mM). After the parasites are taken up during a blood meal, glucose levels fall to
undetectable levels within 15 min (47). Glycosome composition of bloodstream form
(BSF) parasites differs significantly from insect, procyclic form (PCF) parasites (35).
Furthermore, glycosome metabolism (29, 30), glycosome composition (48) and the
requirement for glycosome protein import in the PCF parasite (8) is influenced by
extracellular glucose levels. Despite these observations, most glycosome studies in PCF
parasites have been performed under high glucose conditions and we were curious to
know if glycosome biogenesis varied with extracellular glucose levels. In this work we
focus on PCF parasites because BSF parasites are not viable in glucose-free media.
In our biochemical fractionations, the sedimentation of TbPex13.1 changes with
variation in extracellular glucose levels. Under high glucose conditions, TbPex13.1
equilibrated in fractions containing other glycosome resident proteins. This is in
agreement with previous work (13, 35). We were surprised to find, however, that in low
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glucose media TbPex13.1 was found in fractions of lighter density, which also contained
the ER protein TbBiP. We have repeated these fractionations multiple times with
different cultures and in all cases this glucose dependent localization was observed.
While BiP was detected in all fractions in which TbPex13.1 was present, the
distribution of these two proteins did not overlap completely. We believe there are
several reasons for this behavior. First, the ER is a heterogeneous, branched organelle
with multiple subdomains. The heterogeneous behavior in biochemical fractionations has
also been reported by elsewhere (49, 50). In contrast to the wide distribution of BiP
(fractions 18-30) TbPex13.1, is found in fewer fractions (24-28) and we propose two
explanations for this difference. First, our TbPex13.1 antibodies are not as sensitive as
those for BiP and are therefore likely detecting protein only in fractions in which the
concentration is high. Furthermore, in yeast and mammalian cells peroxisomal proteins
localize to subdomains of the ER from which preperoxisomal vesicles bud (51). It is
possible that the tight distribution of TbPex13.1 in the gradient is caused by localization
within specific regions of the ER.
Our effort to localize TbPex13.1 in PCF cells was complicated by our lack of
TbPex13.1 antibodies that work in IFA. The antibodies we generated against
recombinant TbPex13.1 work in western analysis, but not in IFA. Because of this
limitation, we expressed epitope-tagged TbPex13.1 (HATbPex13.1) in PCF and used
indirect immunofluorescence assays to follow localization. Because initial
characterization of TbPex13.1 was done using green fluorescent protein fused to the Nterminus of TbPex13.1, we reason that our smaller HA tag has minimal influence on the
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localization and function of the protein. In agreement with our biochemical data and the
published literature (13), HATbPex13.1 localized to glycosomes of cells grown in high
glucose. In low glucose, however, the HATbPex13.1 expressing cells had altered ER and
glycosome morphology.
Our fractionation experiments were performed with 3 x 1010 cells (Fig. 4.1). We
have performed such fractionations multiples times with different cultures and are
confident in our ability to resolve the different subcellular compartments under these
purification protocols. However, our transgenic cell lines grow slowly and we are limited
in the number of cells we can harvest. We have tried to scale our fractionation protocol
to accommodate a smaller amount of cells but have, to date, not been able to resolve ER
from glycosomes. This work is ongoing.
In other systems, the PMP exit from the ER through ER exit sites (ERES) (50,
52). If this occurs also in trypanosomes, it may be that the tagged protein is correctly
targeted to the ER but unable to exit either because it cannot be correctly processed or
because its overexpression has exceeded the cells ability to process it. There are other
examples where overexpression of a glycosome protein resulted in alteration of its
resident compartment. Overexpression of TbPex11 in T. brucei resulted in cells that had
clustered and elongated glycosomes (36).
This extraglycosomal localization is likely not due to overexpression of the fusion
protein in low glucose. Western analysis showed that HATbPex13.1 is expressed at
lower levels in low glucose in comparison to high glucose (Appendix, Fig A-1). This
low glucose repression is observed for all TbPex13.1 variants as well as other glycosome
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proteins. Furthermore, it is unlikely that these localization changes are not solely a result
of ER and/or glycosome stress under low glucose conditions as the organelle morphology
is maintained under both conditions (Fig. 4.2).
The structure of TbPex13.1 has been enigmatic. It has two consensus sequences
that are typically involved in localization of glycosome proteins. The Pex19 binding
sequence is present in many peroxisome membrane proteins (25). The chaperone Pex19
binds to the protein in the cytoplasm and then delivers it to peroxisomes. A putative
Pex19 binding domain has been identified in TbPex13.1 but, to our knowledge, has not
be verified experimentally. In addition to the predicted Pex19 binding domain, there is a
C-terminal tripeptide PTS1 sequence. PTS1 sequences bind the soluble receptor Pex5,
which then delivers the cargo to the glycosome membrane. Upon deletion of the PTS1
sequence the protein is localized to glycosomes in glucose rich or glucose poor media.
This finding suggests that PTS1 sequence is not required for glycosome targeting.
Src homology 3 domains (SH3) domains are ~60 amino acids long and form
structural domains that usually mediate protein-protein interactions (53, 54). The SH3
domains of Pex13 in yeast (55) and humans (56) bind directly to Pex5p. Mutations in the
S. cerevisiae Pex13 SH3 domain blocked function, but Pex13 was still targeted to the
peroxisome membrane (55). In yeast two hybrid, the TbPex13.1 SH3 domain interacted
with TbPex13.2 (7). In our experiments, deletion of the SH3 domain also had no impact
on the localization of HATbPex13.1.
Our findings demonstrate that TbPex13.1 localization changes with extracellular
glucose levels and suggests that glycosome biogenesis differs between these two
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conditions. While we have only tested glucose levels there may be other factors such as
temperature and pH that affect glycosome composition and biogenesis. The glucose
dependent phenotype provides further evidence that cellular biology and metabolism of
PCF parasites is profoundly influenced by extracellular glucose levels and that ERglycosome trafficking does occur in trypanosomes. TbPex13.1 may serve as a marker for
following such trafficking in trypanosomes. Elucidation of the ER-glycosome maturation
pathway may lead to the identification of new drug targets.
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Abstract
Trypanosoma brucei is the causative agent of Human African Trypanosomiasis, a disease
affecting approximately 30,000 people per year. T. brucei and other kinetoplastids have
essential, highly specialized peroxisomes that compartmentalize most of the enzymes
involved in glycolysis, called glycosomes. In other eukaryotes, peroxisome composition
is influenced by changes in environmental conditions, including nutrient availability.
Glycosome composition is influenced by extracellular glucose concentration, a nutrient
whose availability changes throughout the life cycle of T. brucei. After the tsetse fly host
takes in a blood meal, glucose is depleted in the procyclic from (PF) environment within
the midgut in 15 minutes. In order to adapt to this change in nutrient availability, PFs can
metabolize proline in the absence of glucose. In the lab, PF parasites are often grown in
media containing ~ 5mM glucose. We are interested in defining the glycosome
composition and behavior under low glucose conditions encountered in the fly. Here, we
present fluorescent and electron microscopy images of glycosomes in parasites grown in
high and low glucose conditions demonstrating changes in overall organelle composition.
Changes in glycosomal protein expression are also seen by western blot analysis.
Additionally, we provide preliminary support that glucose dependent regulation of
glycosomal protein expression may occur at the level of mRNA stability combined with
an overall decrease in translation in cells grown in low glucose conditions compared to
those grown in high glucose conditions. This data will provide insight into the dynamic
nature of glycosomes and how organelles are remodeled to meet the metabolic needs of
cells.
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Introduction
Human African trypanosomiasis is a lethal disease caused by the protozoan
parasite Trypansoma brucei (1). T. brucei has a complex life cycle in which nutrient
availability changes as the parasite is passed between mammalian hosts by the tsetse fly
vector. Bloodstream form (BSF) parasites in mammalian hosts are exposed to high
glucose availability and rely solely on glycolysis for the generation of ATP. Procyclic
forms (PF) in the tsetse fly midgut experience constantly fluctuating glucose availability.
When the tsetse fly first takes in a blood meal, glucose availability in the fly midgut is
similar to that of the mammalian blood stream, approximately 5mM. Within 15 minutes,
glucose concentration has dropped to undetectable levels (2). In the absence of glucose,
PF T. brucei rely on the metabolism of proline for ATP generation (3, 4).
Unlike other eukaryotes in which glycolysis is a cytosolic process, T. brucei
sequester most of the enzymes involved in glycolysis in organelles evolutionarily related
to peroxisomes called glycosomes. This compartmentalization is essential for T. brucei
survival (5–8). Mislocalization of the glycolytic proteins to the cytoplasm results in cell
death (9, 10). Like peroxisomes, glycosomes are single membrane bound organelles
whose biogenesis and protein import are carried out by homologous proteins called
peroxins. Glycosomes lack any DNA so fully folded proteins are imported posttranslationally from the cytoplasm (7, 11, 12). In addition to glycolysis, glycosomes
compartmentalize beta-oxidation of fatty acids, pyrimidine salvage, purine salvage,
pentose phosphate pathway, ether lipid synthesis, and gluconeogenesis (13, 14).
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Peroxisome composition varies depending on the organism and cell type, and can
be influenced by changes in environmental conditions. For example, when
methylotrophic yeast Hansenula polymorpha are grown in conditions where methanol is
the available carbon source, peroxisome proliferation is induced. Transfer back to
glucose containing conditions results in degradation of existing peroxisomes (15).
Similarly, high fatty acid growth conditions trigger peroxisome proliferation in
Saccharomyces cerevisiae, which then degrade their peroxisomes upon transfer back to
glucose containing media (16).
Changes in peroxisome composition correspond to changes in expression of
peroxisomal proteins. Environmentally-dependent transcriptional regulation of
peroxisomal proteins has been demonstrated in yeast and mammals (17–20). In S.
cerevisiae, transcription factors regulate expression of peroxisomal proteins involved in
fatty acid metabolism that are upregulated during peroxisome induction in high fatty acid
conditions (17–19).
Glycosome composition is altered during life cycle differentiation and in response
to environmental changes. During differentiation from BSF to PF, glycosomes are
remodeled by autophagy (21) and differences in glycosome composition between the two
life cycle stages have previously been demonstrated (13). Using a fluorescent organelle
reporter system consisting of a peroxisomal targeting signal (PTS) fused to an enhanced
yellow fluorescent protein (eYFP), we demonstrated that glycosome composition is also
influenced by glucose availability (22, 23).
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Although we have gained understanding of how glycosome composition is
dependent on the life cycle stage and environmental conditions of T. brucei, our
understanding of the mechanism by which they regulate glycosomal protein expression to
coordinate these composition changes is lacking. Unlike most eukaryotes, trypanosome
transcription is polycistronic (24, 25) and thus gene regulation occurs posttranscriptionally. Gene expression is regulated by changes in mRNA stability, levels of
translation, or protein degradation (25). RNA binding proteins regulate mRNA stability
by binding to 3’ untranslated regions (UTR) and can either stabilize the mRNA, increase
efficiency of its translation, or target the mRNA for degradation thereby determining the
half-life of the mRNA (26–28).
PF parasites must adapt to fluctuating glucose availability in the midgut of the
tsetse fly in order to survive (2) and changes in overall glycosome composition in
response to extracellular glucose have been previously demonstrated (22). Here we begin
to characterize the specific changes that occur in glycosome composition in PF T. brucei
in response to changes in glucose availability and investigate the mechanism by which T.
brucei regulates changes in glycosomal protein expression that correspond to changes in
composition.
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Materials and Methods
Growth of parasites.
To compare high and low glucose conditions, cells were cultured in SDM79
media (+Glc) containing 5mM glucose or in SDM80 (-Glc) containing less than 0.5mM
glucose as previously described (3). To ensure cultures were adapted to each condition,
cells were maintained in respective media types for >4 days before being used for
downstream analysis. PF 29-13s were maintained with G418 (15 µg/ml) and hygromycin
(50 µg/ml). Reporter cells line 29-13 pXS2-Aldo-PTS-eYFP (PTS2-FP) were generated
as previously described (22, 23) and were maintained with G418 (15 µg/ml),
hygromycin (50 µg/ml), and blasticidin (15 µg/ml).

Live-cell microscopy.
To compare fluorescence in cells cultured in +Glc and –Glc, PTS2-FP parasites
were harvested by centrifugation at 800xg for 10 min and resuspended in phosphate
buffered saline (PBS). Cells were applied to a clean slide, imaged and analyzed on a
Zeiss Axiovert 200M with Axiovisoin software 4.8.2.

Transmission electron microscopy (TEM).
Samples were prepared for TEM as described in Bauer et al. 2013 (22). To
compare ultrastructural morphology of glycosomes in parasites cultured in +Glc and –
Glc, 29-13s were harvested by centrifugation at 800xg for 10 mins, resuspended in fix
solution (2% paraformaldehyde-2.5% glutaraldehyde in 100mM phosphate buffer) and
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incubated at room temperature for 1 hour. Fixed cells were washed with PBS, postfixed
for 1 hour in 1% osmium tetroxide (Polysciences Inc., Warrington, PA) and washed with
distilled water (dH2O). Cells were en bloc stained for 1 hr with 1% aqueous uranyl
acetate (Ted Pella Inc., Redding, CA) and then washed with excessive dH2O. A graded
series of ethanol solutions was used to dehydrate samples. Cells were embedded in
Eponate 12 resin (Ted Pella Inc.) and 90nm ultrathin sections were obtained using a
Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc., Bannockburn, IL).
Sections were stained with lead citrate and uranyl acetate. A JEOL 1200 EX
transmission electron microscope (JEOL USA Inc., Peabody, MA) was used to image
sections at the Molecular Microbiology Imaging Facility, Washington University School
of Medicine, St. Louis, MO.

Glycosome measurements.
TEM measurements were performed using ImageJ software. Visible glycosomes
were counted and the area of over 100 visible cells and 600 individual glycosomes from
three separate biological replicates per condition was measured. For each condition, the
following calculations were made. Glycosome areas were averaged. Glycosome density
was calculated by dividing the total number of glycosomes by the total area of cells
visible and converting to glycosomes/100µm2. Percentage of total cell area was
calculated by dividing the sum of all glycosome areas by the sum of all cell areas and
multiplying by 100%.
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Western blot analysis of glycosomal proteins.
To compare changes in expression of glycosomal proteins, 1x106 cells were
harvested at 800xg for 10 mins and resolved by 12% SDS-PAGE. After transfer,
membranes were probed with antibodies against T. brucei PEX13.1 (1:10,000), PEX11
(1:4,000) (provided by Christine Clayton, Univerisität Heidelberg, Heidelber, Germany),
aldolase (1:50,000), hexokinase (1:100,000), and commercially available tubulin
(1:8,000) (Millipore clone YL1/2, Temecula, CA). Signal quantification was performed
using ImageJ software.

Quantitative Real Time PCR.
Cells were harvested (2x106) and RNA was isolated using the Aurum Total RNA
Mini Kit (BioRad). Quantitative real time PCR was carried out using the Verso SYBR
Green 1-step kit with primers for PEX13.1, PEX11, aldolase, and hexokinase. Relative
quantification of mRNA was compared to the housekeeping genes Hypoxanthine-guanine
phosphoribosyltransferase (HGPRT) and 60s rRNA using the 2-ΔΔCt method.

Glycosomal protein half-life.
To determine protein half-life, cells grown under each condition were treated with
100µg/ml of cycloheximide. For western blot analysis, 2x106 cells were harvested
immediately prior to treatment (P), immediately following treatment (0), at 1 hour (1), 2
hours (2), 4 hours (4), and 6 hours (6). Samples were resolved by SDS-PAGE. Western

117

blots were probed with anti-aldolase (1:50,000) as a glycosomal representative, and
tubulin (1:8,000) (Millipore clone YL1/2, Temecula, CA) as a control.

Ribosomal profile analysis.
To compare overall levels of translation in +Glc and –Glc, polysomes from each
condition were isolated and polysome profiles were generated using methods adapted
from Brecht et al. 1998 (29). Briefly, 5x108 cells were harvested at 800xg for 10
minutes, resuspended in 5mL of media containing 100µg/ml cycloheximide and
incubated for 5 min. Cells were centrifuged for 800xg for 10 mins and washed with ice
cold PBS containing 100µg/ml cycloheximide, 1µM DTT, and ~5U/µL RNasin. Cells
were resuspended in 750µL ice cold buffer A (10mM Tris-HCL, pH 7.4; 10mM MgCl2;
300mM KCl; 100µg/ml cycloheximide; 1µM DTT; ~U/µL RNasin) and incubated on ice
for 3 minutes. 125µL of lysis buffer (buffer A with 1.0% (v/v) Triton X-100 and 0.2M
sucrose) was added and cells were passed through a 21G needle 20-30 times. Lysate was
centrifuged at 15,000xg for 10 min at 4°C. Supernatant was transferred to a tube with
32µL of 5M NaCl, 100µL heparin, and 1µL of 40U/µL RNasin. For a control, samples
were divided in half and 10µg/mL puromycin was added to the control sample for each
condition to dissociate polysomes. 400µL of extract from each sample and control
sample was added to a 3mL 15-50% sucrose gradient and centrifuged for 2 hours at
230,000xg at 4°C. 25 fractions of 30µL were pipetted from the top of the gradient and
loaded directly into a 96 well UV plate. Then 30 fractions of 75µL were pipetted from

118

the top of the remaining gradient and placed in labeled tubes. 30µL from each tube was
loaded into the same 96 well. The OD254nm was measured for each plate and data points
were plotted in Microsoft Excel to generated a polysome profile curve.

Results
Glycosome composition is heterogeneous is low glucose conditions.
We previously adapted a fluorescent organelle reporter system commonly used to
study peroxisome dynamics in yeast and mammals to T. brucei. Reporter cell lines
express the PTS2 of aldolase fused to eYFP, enabling visualization of overall changes in
glycosome composition by microscopy (22, 23). We cultured these cells in +Glc media
and –Glc media and found that in +Glc media, glycosomes are homogenous and
distributed throughout the cell (Fig 5.1A). However, under low glucose conditions
glycosomes are heterogeneous with some cells having glycosomes distributed throughout
the cell, much like +Glc, and other cells appearing to have fewer PTS-FP positive
glycosomes (Fig 5.1B).
We next analyzed cells grown in +Glc and –Glc media by TEM (Fig 5.1C and D).
Although average glycosome area remained similar under both conditions being
0.074µm2 and 0.084µm2 for +Glc and –Glc respectively, contrary to the fluorescent
reporter cell data there were approximately four times the number of glycosomes per
100µm2 in –Glc compared to +Glc (Fig 5.1E and F). Glycosomes made up only 1.46%
of the total cell area in +Glc but 7.21% in –Glc (Fig 5.1G). In addition, in +Glc the
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electron density appeared to be similar in all glycosomes, while in –Glc there was a
greater diversity in electron density. These findings suggest that there may not be fewer
glycosomes in PTS-FP cells grown in –Glc media, just fewer PTS-FP positive
glycosomes.

Figure 5.1. Glycosome composition changes in response to glucose availability.
Live cells expressing PTS-FP grown in +Glc (A) and –Glc (B). TEM images of cells
grown in +Glc (C) and –Glc (D) with glycosomes indicated by orange arrows (scale bar =
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0.5µm). Average area of glycosomes (E), number of glycosomes/cell area (F), and
percent cell area comprised of glycosomes (G).

Glycosomal protein expression is down regulated in low glucose conditions.
Colasante et al used mass spectrometry to compare the proteome of glycosomes
isolated from PF and BSF cells. In this study, they demonstrated that only 35% of
glycosomal proteins were present in both life cycle stages, while 23% were BSF specific
and 42% were PF specific (13). To assess such changes in protein expression in PF cells
grown in +Glc and –Glc, we did western blot analysis probing whole cell lysate with a
number of known glycosomal antibodies including two membrane bound peroxins
involved in glycosome biogenesis, PEX13.1 (30) and PEX11 (31), and two matrix
proteins involved in glycolysis, aldolase and hexokinase (32). We quantified expression
of each of these proteins under the two conditions and found that PEX13.1 and aldolase
were downregulated more than 2 fold in –Glc compared to +Glc (Fig 5.2A and B).
PEX11 was slightly downregulated in –Glc and Hexokinase was upregulated in –Glc.

Glycosomal protein mRNA abundance change in low glucose conditions.
Trypanosomes can regulate protein expression by regulating mRNA stability (25).
We performed qRT-PCR and analyzed glycosomal protein mRNA levels relative to
reference genes, HGPRT and 60s rRNA, using the 2-DDCt method. Corresponding to
protein expression, PEX13.1 and PEX11 mRNA levels were reduced while hexokinase
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was upregulated in –Glc (Fig 5.2C). Aldolase mRNA abundance was similar under both
conditions. This data combined with protein expression data (Fig 5.2) suggests that
PEX13.1, PEX11, and HK expression may be regulated at the level of mRNA abundance
while aldolase expression could be regulated by a mechanism other than mRNA stability,
such as translation or protein degradation. Although changes in mRNA levels were
statistically significant, we have yet to confirm their biological significance. In the
future, more replicates will help us to better understand the relationship between mRNA
abundance and glycosomal protein expression.

Aldolase protein expression is not regulated by degradation.
Protein abundance can be regulated through protein degradation via targeting to
the proteasome or lysosome (33). To determine if aldolase protein expression is
influenced by changes in protein half-life, we treated cells with cycloheximide to inhibit
protein expression and monitored glycosomal protein levels over time via western blot
analysis. We found that aldolase was very stable, having a half-life greater than 6 hours
in both +Glc and – Glc (Fig 5.3A and B) in agreement with previous findings by Clayton
1987 (34). Tubulin half-life was approximately 2 hours, as previously determined (35).
Such stability suggests that aldolase expression regulation occurs by a mechanism other
than protein degradation.
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Figure 5.2. Glycosome protein expression is down regulated and mRNA abundance
is altered in low glucose.
(A) Cells were grown in +Glc and -Glc and protein expression measured by western
analysis using antibodies against different glycosome proteins. (B) Bands on the western
blots were quantitated using Image J. (C) mRNA was quantified by qRT-PCR, and
analyzed by the 2-ΔΔCt method. (+Glc: grey; -Glc: purple)
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Figure 5.3. Aldolase stability is not altered in low glucose.
Cells grown in +Glc (A) and -Glc (B) were incubated with cyclohexamide to block
translation. Cell lysates from pre-treated cells (P) and time points taken at 0 through 6
hours were analyzed by western blotting with anti-aldolase antibodies.

Association of mRNA with polysomes is decreased in low glucose conditions.
To measure changes in overall protein translation in response to changes in
glucose availability, we used density gradients to isolate actively translating ribosomes
(polysomes) and the messages associated with them. Preliminary polysome profiles
suggest that there is an overall decrease in the amount of polysomes and increase in free
ribosomes in –Glc compared to +Glc (Fig 5.4) suggesting that protein translation is
downregulated in –Glc. It is possible that the decrease in overall translation could also
play a role in the downregulation of glycosomal protein expression, however, this is
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unlikely as we have yet to observe a reduction of non-glycosomal proteins under low
glucose conditions.

Figure 5.4. Polysomes decrease in low glucose conditions.
Cells were grown in +Glc (blue) and –Glc (red). Fractions from each sucrose gradient
were collected by hand and measured at OD254nm. Polysome profile was generated by
plotting the OD254nm measurements in Microsoft Excel.

Discussion
Previous studies in glycosome composition have primarily been conducted in high
glucose conditions (13, 14). Glucose concentration remains at undetectable levels the
majority of the time for PF T. brucei in the tsetse fly midgut. Only when the fly takes in
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a blood meal will the glucose availability spike to that of mammalian blood (~5mM) (2).
Glycosome composition changes during BSF and PF life cycle stages to better adapt the
parasites to the environmental conditions encountered in hosts and vector (13). In a
similar manner, it seems logical that PF glycosomes, as the home of the first seven
glycolytic enzymes in PF cells as well as a number of other metabolic pathways (13, 14),
would be dynamic and have compositions that fluctuate in response to changes in nutrient
availability. Gaining understanding of the changes in glycosome composition that occur
in both high and low glucose conditions and the mechanisms by which these regulations
occur could provide new understanding about glycosome plasticity and how parasites
adapt to changes in nutrient availability.
In this study we examine how glycosome composition is influenced by changes in
extracellular glucose. We first utilized PTS-FP cells to observe differences in overall
glycosome composition. We find that while in +Glc cells appear to have homogeneous
glycosome distribution, in –Glc glycosome distribution in cells is more heterogeneous
with some cells appearing to have fewer glycosomes. This is contradictory to the TEM
image analysis demonstrating that in –Glc cells have ~4X the number of glycosomes (Fig
5.1). Together this data suggests that in –Glc there may be PTS-FP negative glycosomes
not visible by fluorescence microscopy. This would explain why cells that have more
glycosomes appear to have less when expressing PTS-FP.
We believe that this could be a reflection of cells possessing more than one
population of glycosomes under low glucose conditions. We hypothesize that there is
more than one “type” of glycosome and that under different conditions certain types may
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predominate. Preliminary results from our lab of mass spectrometry analysis of
glycosomes isolated from +Glc and –Glc suggest that in –Glc conditions enzymes
involved in gluconeogenesis are enriched more than two fold (Appendix Fig A-2). It is
possible that in –Glc conditions cells could be increasing the number of glycosomes that
contain gluconeogenic activity and that our reporter PTS-FP may not be imported into
these organelles.
Environmentally influenced changes in expression and localization of some
peroxisomal proteins have been demonstrated to occur in S. cerevisiae when grown on
oleate compared to glucose (36). We noted a decrease in expression in glycosomal
proteins when cells were grown in –Glc (Fig 5.2). The proteins that we probed against
were two matrix proteins involved in glycolysis, hexokinase and aldolase (32), and two
membrane bound peroxins involved in glycosome biogenesis, PEX11 (31) and PEX13.1
(30). If our hypothesis that there is more than one kind of glycosome is correct, we may
see an increase in expression in certain glycosomal proteins involved in processes other
than glycolysis in –Glc compared to +Glc, such a gluconeogenesis. As a protein
involved in glycosome biogenesis, we were surprised to see a decrease in PEX13.1
expression. However, T. brucei also expresses a second PEX13 that is likely involved in
matrix protein import called PEX13.2 (37). It is possible that PEX13.1 and PEX13.2 are
present in different types of glycosomes and help to regulate the proteins imported into
each population of organelles. It was recently demonstrated in S. cerevisiae that a matrix
protein receptor peroxin, PEX9, selectively imports specific peroxisome matrix proteins
in an environmentally dependent manner (38, 39). If PEX13.1 and PEX13.2 are in
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different types of glycosomes, we may see an increase in expression of PEX13.2 in –Glc
conditions. We are in the process of generating antibodies against a PEX13.2 peptide.
Although we see an increase in expression in the glycolytic enzyme hexokinase, we
believe this protein may be moonlighting in a role outside of glycolysis in low glucose
conditions.
We are currently in the process of conducting mass spectrometry analysis on
glycosomes isolated from cells grown in +Glc and –Glc to gain understanding about the
detailed molecular differences in glycosome composition under these two conditions. In
an effort to determine if there are more than one population of glycosomes, we plan to
conduct microscopy experiments comparing the localization of enzymes involved in a
number of different glycosomal processes. A partial or total lack of colocalization
between glycosomal proteins involved in different processes would provide support that
more than one population of glycosome exists. In the future, isolating different
glycosomal populations would allow for detailed mass spectrometry analysis of enzyme
content, providing information about the division of functions between populations.
S. cerevisiae regulates nutrient dependent expression of peroxisomal proteins
through the activation of transcription factors (17–19). T. brucei transcription is
polycistronic and thus most regulation occurs post-transcriptionally (25). To determine
the mechanism by which T. brucei regulates environmental dependent expression of
glycosomal proteins, we first compared overall levels of the mRNA of glycosomal
proteins, PEX13.1, PEX11, aldolase, and hexokinase. In most studies conducted to date
mRNA half-lives depend on sequences within their 3’ UTR that are recognized by RNA
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binding proteins that can stabilize mRNAs or target them for degradation (25–28).
Destabilization of glycosomal protein mRNA in –Glc could provide a way to decrease
expression. By western blot analysis we see a decrease in PEX13.1, PEX11 and aldolase
and an increase in hexokinase (Fig 5.2A and B). Similarly, we see a statistically
significant decrease in mRNA levels for PEX13.1 and PEX11 and an increase in
hexokinase mRNA (Fig 5.2C). While aldolase protein expression is decreased in –Glc
compared to +Glc, mRNA levels remain unchanged. Based on our findings it is possible
that regulation of glycosomal proteins occurs at the level of mRNA stability.
We treated cells with cycloheximide to look for differences in protein half-life
under +Glc and –Glc. Under both conditions aldolase was very stable, with a half-life
beyond 6 hours suggesting that protein degradation may not play a role in aldolase
protein expression regulation (Fig 5.3).
We are in the process of examining the role of translational regulation of
glycosomal proteins. Preliminary data comparing polysome profiles from cells grown in
+Glc and –Glc demonstrate a decrease in the number of polysomes in low glucose
conditions (Fig 5.4). It is possible that regulation of glycosomal proteins could result
from an additive effect of down regulation of mRNA message and decrease in overall
translation. It is unlikely that this decrease in overall protein translation in –Glc
conditions alone results in a decrease in glycosomal protein expression. If this were the
case, we would also expect to see reduced expression of non-glycosomal proteins – a
phenotype which we have yet to observe.
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While mRNA levels of some of the glycosomal proteins that we have investigated
so far correlate to amount of protein, this may not be the case for other proteins as it has
been demonstrated that in trypanosomes mRNA and protein levels only moderately
correlate (40–42). We have yet to identify the mechanism by which aldolase expression
is decreased in –Glc. Regulation of glycosomal protein expression may be multifaceted
and depend on the kind of protein (ie membrane bound vs. matrix, peroxin vs. metabolic,
etc.) or the type of stimulus initiating glycosomal remodeling.
We are in the process of gaining a better understanding of the mechanisms T.
brucei uses to regulate glycosomal proteins. Northern blot analysis of polysome fractions
probing against glycosomal protein mRNA may provide insight as to whether there is a
change is translation of glycosomal proteins between +Glc and –Glc. We also plan to
conduct RNA-seq on RNA isolated from whole cells and from polysome fractions. This
will enable us to compare whole cell level of mRNA messages to what is actively being
translated providing insight into the correlation of mRNA abundance and protein
translation. If mRNA abundance appears to play a key role in the regulation of
glycosomal proteins, detailed comparison of their 3’ UTR sequences may identify
specific binding sights for RNA binding proteins that could be stabilizing or
destabilitzing these messages. In addition, mass spectrometry analysis of whole cells
grown in +Glc and -Glc to compare RNA binding protein expression under both
conditions may help to identity binding proteins potentially involved.
The findings discussed in this paper demonstrate a level of glycosome
heterogeneity heretofore unappreciated. Regulating glycosomal composition is likely
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essential for T. brucei to adapt metabolic needs to changing environmental conditions.
Although standard lab procedure is to culture PF T. brucei in the presence of glucose,
culturing under low glucose conditions may give a more realistic picture of parasite
biochemistry in the tsetse vector host. While we have focused our efforts on
characterizing the differences in response to changes in glucose availably, there may be
other metabolites or environmental factors that can influence glycosomal protein
composition and expression. Better understanding of how T. brucei parasites adapt to
changing environmental conditions could lead to identification of new drug targets.
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CHAPTER SIX
SUMMARY AND FUTURE DIRECTIONS
Historically, Trypanosoma brucei glycosomes were considered to be static
organelles within the mammalian bloodstream form (BSF) and tsetse fly vector procyclic
form (PF) life cycle stages. Five years ago, our understanding was that organelles within
each stage harbored a defined proteome (1) which was remodeled only during
differentiation (2). PF glycosomes sequester a number of metabolic pathways including
glycolysis, purine salvage, pyrimidine biosynthesis, peroxide metabolism, beta-oxidation
of fatty acids, the pentose phosphate pathway (1, 3), and gluconeogenesis (4–6). T.
brucei PF parasites preferentially utilize glycolysis for the generation of ATP but in the
absence of glucose are capable of metabolizing proline to generate ATP and to produce
glucose via gluconeogenesis, feeding the pentose phosphate pathway for NADPH
production (4).
Unlike peroxisomes in other eukaryotes whose biogenesis occurs both through
growth and division and ER-derived de novo mechanisms (7, 8), trypanosome
glycosomes were thought to proliferate only through growth and division of existing
organelles (9) while evidence for a de novo mechanism was scarce. In addition,
traditional lab procedures entailed culturing PF parasites in media containing 5mM
glucose, in stark contrast to the tsetse fly midgut where glucose remains at undetectable
levels with occasional and brief spikes to ~5mM during the 15 minutes immediately
following a blood meal (10).
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The work presented in this dissertation provides a few examples of how our
understanding of glycosomes has changed in the recent half decade. In Chapter One, we
review recent findings offering support for the existence of a mechanism of de novo
glycosomes biogenesis in T. brucei. Chapter Two and Three summarize our
methodology using the fluorescent organelle reporter, PTS-FP, to demonstrate how
glycosomes are dynamic organelles in PF T. brucei. Our results show that glycosome
composition changes in response to glucose availably and that changes in extracellular
environment can induce remodeling of glycosomes in a time frame consistent with
autophagy (11, 12). De novo glycosome biogenesis following autophagy could provide a
rapid mechanism to restore glycosome populations better suited for new environmental
conditions or life cycle stages.
In Chapter Four we present evidence of a peroxin involved in glycosome matrix
protein import, TbPEX13.1, exhibiting glucose dependent localization. In media
containing glucose TbPEX13.1 localizes to glycosomes as previously published.
However in low glucose conditions, TbPEX13.1 appears to localize to the ER (13).
Localization of PEX13 to the ER in yeast and mammals occurs during ER-derived de
novo biogenesis of peroxisomes (14–17). Such change in localization suggests that
glycosomes may be proliferating through different mechanisms under each condition,
relying on growth and division in high glucose conditions and de novo processes under
low glucose conditions. Different mechanisms of biogenesis could contribute to the
heterogeneous glycosome populations exhibited in low glucose conditions discussed in
Chapter Five.
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We now understand that glycosomes are dynamic, heterogeneous organelles
whose composition can be remodeled to adapt PF T. brucei to changes in environmental
conditions. Contrary to the static model of glycosome composition in which organelles
only replicate through growth and division, the findings presented in this dissertation
have lead us to a different model. We hypothesize that PF parasites harbor different
populations of glycosomes with distinct protein compositions specializing in specific
glycosomal functions and that changes in environmental conditions and metabolic needs
for cells could result in a redistribution of these populations (Fig 6.1).
In Chapter Five, we show that cells cultured in low glucose conditions have
approximately four times the number of glycosomes visible by EM with varying electron
densities (Fig 5.1). Fluorescence images of cells expressing PTS-FP show that low
glucose cultured parasites appear to have fewer PTS-FP positive glycosomes compared to
high glucose conditions suggesting that there are different glycosome populations, with
different matrix protein repertoires.
In Chapter Two, we identified two populations of PTS-FP cells in culture: a bright
population and a dim population (Fig 2.2). At the time we hypothesized that these may
be mature import competent and immature import incompetent glycosomes based on the
fact that a number of glycosomal proteins in the dim population were undetectable by
western blot analysis, including PEX13.1 (11). The data presented in Chapter Five now
leads us to believe that these may be different populations of glycosomes all together.
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Figure 6.1. Hypothesized model of environmentally regulated glycosome
heterogeneity and dynamic biogenesis.
Green glycosomes represent PTS-FP positive glycosomes that contain enzymes involved
in glycolysis. TbPEX13.1 serves as the docking complex in these organelles. Purple
glycosomes represent PTS-FP negative glycosomes containing the enzymes involved in
gluconeogenesis. We propose that TbPEX13.2 may serve as the docking complex in
these organelles. Different proportions of green and purple glycosomes exist in +Glc and
–Glc and may be regulated by adjusting the contribution of growth and divisions, which
predominates in +Glc, and ER-derived de novo biogenesis, which predominates in –Glc.
Differences in matrix proteins repertoire between green and purple glycosomes could
extend beyond glycolysis and gluconeogenesis which are highlighted here for simplicity
and will be investigated in greater detail in the future.
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Preliminary mass spectrometry analysis of cells cultured in low glucose
conditions (where we see such heterogeneous glycosome populations), show a two-fold
increase in the proteins involved in gluconeogenesis (Appendix Fig B-1). In dim
populations FBPase, a gluconeogenesis specific enzyme, and triosephosphate isomerase
(TIM), a bidirectional enzyme involved in gluconeogenesis and glycolysis, are both
detectable by western analysis in while other glycosomal enzymes are not (Fig 2.2). In
addition, glycosome densities appear to be similar in TEM images captured of bright and
dim populations (Fig 2.3) (11) suggesting that dim cell glycosomes do contain protein
and are not empty, immature organelles. It is possible that the cells with fewer PTS-FP
positive glycosomes in low glucose conditions discussed in Chapter Five and the dim
cells discussed in Chapter Two contain a greater proportion of glycosomes that are PTSFP negative and harbor gluconeogenesis or other glycosomal metabolic processes and not
glycolysis. Gluconeogenesis has been demonstrated to play a role in NADPH
homeostasis in T. brucei grown under low glucose conditions (4). An increase in the
number of glycosomes specializing in gluconeogenesis could reflect a need for NADPH
production.
In addition to changes in matrix protein expression, we also noted a decrease in
TbPEX13.1 expression in dim cells compared to bright cells in Chapter Two (Fig 2.2)
(11) and in cells cultured in low glucose conditions compared to high glucose conditions
(Fig 5.2 and Fig A-1). As previously discussed in Chapter Five, it is possible that T.
brucei’s second PEX13, TbPEX13.2 (18), could be serving as the acting PEX13 in this
second type of glycosome. Environmentally induced expression of PEX9 in
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Sarcchomyces cerevisiae has been demonstrated, where this peroxin selectively imports
certain proteins into peroxisomes serving as a mechanism to remodel these organelles in
response changes in carbon source availability (19, 20). In a similar manner TbPEX13.1
and TbPEX13.2 could each serve as the docking complex of specific types of
glycosomes, regulating import of only glycosomal matrix proteins involved in specific
functions.
A change in the mechanism of organelle biogenesis reviewed in Chapter One
could provide a way to adjust proportions of glycosome populations. By altering the
level at which growth and division and de novo organelle biogenesis contribute,
glycosome composition could be regulated based on the metabolic needs of the cell.
Localization of TbPEX13.1 to the ER under low glucose conditions (Fig 4.4) may be a
reflection of changes in glycosome biogenesis as the cell adapts to changes in
extracellular glucose (13).
In the future, we plan to test this hypothesis by comparing localization of
TbPEX13.1 and TbPEX13.2 as well as different glycosomal metabolic pathways, such as
glycolysis, gluconeogenesis, and purine salvage. If different types of glycosomes exist,
staining for enzymes involved in different metabolic pathways may show little to no
overlap in immunofluorescence colocalization studies. If different organelle populations
can be identified, isolation of the different types of glycosomes and mass spectrometry
analysis of each could provide a detailed picture of the differences in protein repertoire
and function of each population.
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Our understanding of glycosomes has drastically changed in the past
decade. We now appreciate that these organelles are heterogeneous and dynamic and that
regulation of their composition is likely essential for adaptation to changes in
extracellular environment for T. brucei. Traditional methods of PF culturing limit the
amount of knowledge we can gain about glycosome biogenesis and maintenance that is
likely exhibited in the tsetse fly midgut as cells are cultured in a consistently higher and
more stable concentration of glucose than PF cells normally encounter in the wild. To
more accurately study cellular and metabolic processes in PF T. brucei, culturing in low
to no glucose conditions that are more similar to what the parasite encounters in the wild
should be considered. While we have demonstrated that glucose availability influences
glycosomes composition (11, 13) and likely biogenesis, we have yet to test other factors
that may have similar effects on T. brucei cell biology, such as changes in cell density,
temperature, pH, or in availability of other nutrients. Gaining understanding of how
changes in glycosome composition enable T. brucei’s adaptation to changes in
environmental conditions could lead to the discovery of new drug targets – a crucial goal
in our battle to end the suffering of human African trypanosomiasis.
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Appendix A
HATbPEX13.1 Expression

Figure A-1. HATbPEX13.1 expression is down regulated under low glucose conditions.
Cells (2 x 106) grown in SDM79 and SDM80 were pelleted, boiled in cracking buffer,
and resolved by SDS-PAGE. Western blots were probed with anti-HA and anti-BiP
antibodies.
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Appendix B
Preliminary Mass Spectrometry Analysis
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Figure B-1: Mass spectrometry analysis was performed on glycosomes isolated from
cells grown in high glucose media (+Glc) and low glucose media (–Glc) via sucrose
gradient density centrifugation. A total of 450 glycosomal proteins were identified
(protein groups plotted in “Glycosome proteins” pie chart). The abundance of 58 proteins
was influenced by glucose availability. 22 of those proteins were enriched >2 fold in
glycosomes isolated from cells cultured in +Glc (protein groups plotted in “Enriched in
glucose containing media” pie chart). 36 proteins were enriched >2 fold in glycosomes
isolated from cells cultured in –Glc (protein groups plotted in “Enriched in low glucose
media” pie chart).
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